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Abstract
Inhaled particles reaching the alveolar walls have the potential to cross the blood gas barrier and
enter the blood stream. Pulmonary dosimetry, however, is not well understood. Numerical and
experimental studies shed some light on the mechanisms of particle transport, but realistic
geometries have not been investigated. In order to accurately predict particle deposition, the
characteristics that affect deposition need to be understood. This includes, but is not limited to,
fluid flow, lung morphology, breathing conditions, and particle concentration. Various
geometries have been used for research, but very few are close representations to in vivo
geometry. Most studies have used simplified or idealized geometries based on published
dimensions, but none replicate actual in vivo geometry; even fewer examine the differences that
exist between healthy and diseased lung geometries.

The following work analyzes and compares the flow fields that exist in replica healthy and
emphysemic lungs by using realistic geometries and breathing conditions. Actual human lung
casts for in vivo healthy and emphysemic geometries were obtained, scanned, and used to
reconstruct three dimensional replica models. From these geometries, hollow compliant models
were created and used to simulate breathing under healthy and diseased conditions.

It was

shown that major geometric differences exist between the healthy and emphysemic models.
Specifically, the emphysemic model alveoli appeared to merge into a single large alveolus with
no potential regions of recirculation, as compared to the healthy model, which contained smaller,
more distinct alveoli, and an overall model volume 11x smaller than the emphysemic model.

Each experimental geometry was examined using stereoscopic particle image velocimetry
(stereoPIV) techniques. Realistic flow conditions were derived by the application of scaling
theory to convert from the in vivo size to the large scale experimental set up. Experimental
techniques were validated by comparing to computational fluid dynamic (CFD) results when
using a simplified three-dimensional (3D) bulb geometry. Following validation, experimental
flow fields were examined, on the large experimental scale, using velocity and streamline plots,
for healthy and emphysemic geometries. It was shown that reversible flow was present in both
models; even in locations representing a high probability for recirculating or irreversible flow.
i

Each of the experimental flow fields was then scaled to represent in vivo velocity predictions.
The emphysemic model (run under normal emphysemic breathing conditions) had a flow rate 8x
that of the healthy model with normal breathing. The inlet velocity for the healthy normal
breathing model, however, was 1.6x larger than the emphysemic. These flow results are a
function of both the model geometry and the applied realistic breathing conditions. The
distribution of in vivo velocity magnitude over the flow field was also different between the
healthy and emphysemic models. Specifically, the healthy model enters at higher velocities than
the emphysemic, and then uniformly slows as the fluid moves towards the walls. The
emphysemic model yields a large region of fast flow near the inlet and slows at random locations
as it approaches the walls. It was reasoned that even though inhaled particles would likely travel
further into the emphysemic model compared to the healthy, the distance to reach the wall would
be much greater in emphysema as compared to healthy. This would result in higher deposition
efficiencies for healthy models as compared to emphysema, which is consistent with results
found in the literature.

ii
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Chapter 1: Introduction and Background Information
1.1 – Anatomy of the Lung
The human respiratory tract is divided
into three sections: the upper respiratory
tract (consisting of the nasal passages
and throat), the respiratory airways
(made up of the larynx, trachea, bronchi,
and bronchioles), and the lungs
(consisting of respiratory bronchioles,
alveolar ducts, alveolar sacs, and
alveoli). While most of the respiratory
tract exists mostly to direct air to the
lungs, the alveoli are the only part of the
lung where oxygen and carbon dioxide
exchange occurs (referred to as the
pulmonary region). Each human lung

A

B

Figure 1.1 - (A) Subdivisions of the pulmonary airways and (B)
the acinus region of the human lung (Netter 1979).

contains approximately 300 million
alveoli with an average effective airway diameter of 200 to 300 microns (Angus and Thurlbec
1972). Figure 1.1 illustrates the anatomy of the most distal regions of the human lung; the
bronchioles and acinus regions (occurring between generations 20 and 23). Understanding the
fluid mechanics occurring in the acinus region is of high importance because it is the region
where gas exchange occurs.

Emphysema is a chronic obstructive disease of the lung
that occurs in the acinus region. It is classified as a
chronic obstructive pulmonary disease (COPD). Over
time, septa walls break down and air sacs lose their
elasticity causing air to be trapped in the sacs. This
increases the overall volume of the alveolar sacs and

A

B

Figure 1.2 - Illustrations of (A) healthy and
(B) emphysemic alveoli (Metro Health
System 2008).
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decreases the surface area through which gas exchange occurs. It becomes increasingly difficult
to expel carbon dioxide from the lungs causing a starvation for oxygen. Figure 1.2 depicts the
differences in geometry between healthy and emphysemic alveoli. It is seen that the septa walls
of the emphysemic sac have deteriorated causing individual alveoli to join into a single large
alveoli. Fifteen million Americans are currently affected by emphysema/COPD with 80-90% of
the cases caused by smoking (Sciences 2009).

Particle deposition in the pulmonary regions of the lung is not well understood; mainly because
the current models do not reflect in vivo geometry. In order to accurately predict deposition in
various regions, the characteristics that affect deposition need to first be understood. This
includes fluid flow, lung morphology, breathing conditions, and particle concentrations or dose.

1.2 – Alveolar Numerical and Experimental Models Found in Literature
Many studies have examined the complex flow patterns in the pulmonary regions with
increasingly more sophisticated geometries. Tsuda et al. (1995)
were some of the first researchers to study fluid mechanics in the
alveolar region of the lung. They developed a moving boundary
circular channel geometry surrounded by a torus, an
axisymmetric representation of an alveolus (Figure 1.3), and
performed numerical simulations to predict the fluid flow in
various regions of the lung. The dimensions of the torus were
varied to depict various lung generations. The ratio of the depth,
D, distance from the mouth opening to the bottom of the torus, to
the mouth diameter, MD, distance of the mouth opening
perpendicular to the depth, (D/MD), ranged from 0.50 to 0.87. A

Figure 1.3 - Axisymmetric alveolus
used by Tsuda et al. (1995) and
Tippe and Tsuda (2000). QA =
alveolar flow rate, QD = ductal flow
rate, RA = alveolar radius, RD =
ductal radius, γ = opening half angle.

terminating sac, however, was not studied. This geometry was
also used in the experimental research performed by Tippe and Tsuda (2000).

Recently, more complex geometries have been created to better understand the complex in vivo
flow patterns. A comparison was completed on published work that dealt primarily with the
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lower generations, ideally terminating alveolar sacs and proximal generations. The following
studies were chosen based on similar scopes to the completed work in this document.

Darquenne (2001) performed a computational fluid dynamic (CFD) simulation on a static wall
geometry consisting of a symmetric channel surrounded by
triangular shaped alveoli (Figure 1.4) with a D/MD ratio of
1.03; representing generations 18 through 20.

Karl et al. (2004) performed both numerical and
experimental procedures on a stationary wall central channel
geometry
surrounded by
numerous alveoli
Figure 1.4 - Symmetric channel
geometry used by Darquenne (2001).

with a D/MD ratio

Figure 1.5 - Central channel geometry used
by Karl et al. (2004).

ranging from 0.17 to 1.00 (Figure 1.5). These values are
representative of generations from the acinus region to an alveolated duct.

Sznitman et al. (2007a; 2009) completed moving boundary numerical simulations on an
alveolated duct with a single alveolus
(Figure 1.6A), and on a truncated
octahedron (14-hedron) geometry
(Figure 1.6B). The single alveolus
model’s D/MD ratio ranged from 0.87
to 0.90, representing the 15th
generation to the 23rd generation, but
did not contain a terminal sac. In the

A

B

Figure 1.6 - (A) Alveolated duct geometry used by Sznitman et al.

octahedron model, however, the D/MD (2007a) and (B) Truncated octahedron geometry used by Sznitman
et al. (2009).
ranged from 1.02 to 2.00 and
represented generations labeled 3 through 8 (0 representing the transitional bronchioles); and
included a terminating sac.
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Similar to Karl et al. (2004), van Ertbruggen et al.
(2008) performed both numerical and
experimental studies on an alveolated duct. Their
model consisted of two alveolated ducts joined by
a 145° bend and can be seen in Figure 1.7. The

B

Figure 1.7 - Alveolated duct model used by van
Ertbruggen et al. (2008). (A) Model dimensions, (B)
experimental setup, and (C) numerical model.

stationary wall geometry had a D/MD of 1.50
representing the 21st generation.

Oakes (2010; 2008) presented thesis work pertaining to experimental PIV research on moving

A

B

boundary models of both healthy and diseased
idealized geometry (Figure 1.8). For the healthy
model, a D/MD ratio of 0.66 was used, while 0.43
was used for the emphysema model. Both of the
models represented terminating sacs, occurring at the
23rd generation.

C

D
Similar in geometry to Oakes (2010; 2008), Kumar
et al. (2009a) studied two honeycomb-like polygonal
structures representing generations 18 to 22 and a
terminating 23rd generation (Figure 1.9). Because of

Figure 1.8 - Idealized geometry used by Oakes
(2008). Healthy model (A) front and (B) top.
Emphysemic model (C) front and (D) top.

the complex geometry, the D/MD ratio was
undetermined.

A wide variety of experimental and
numerical parameters have also be been
studied, including constant input flow rates
(van Ertbruggen et al. 2008; Darquenne
2001; Karl et al. 2004), non-constant
breathing curves (Tsuda et al. 1995; Tippe
and Tsuda 2000), and sinusoidal breathing
curves (Sznitman et al. 2007a; Sznitman et

A

B

Figure 1.9 - Honeycomb geometry used by Kumar et al.
(2008). (A) Geometry representing generations 18 to 22 and
(B) terminating alveolar sac representing the 23rd generation.
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al. 2009; Kumar et al. 2009a). Oakes (2010; 2008), however, used a spirometry derived
breathing curve; indicative of a healthy human breathing under normal conditions.

1.3 – Summary of Alveolar Model Results from the Literature
It was determined that the flow rate ratio (ratio of the alveolar flow rate to the ductal flow rate) is
of great importance when studying alveolar flow mechanics. Based on prior results, reversible
flow is present when the flow rate ratio is greater than or equal to 0.05 (Tsuda et al. 1995; Tippe
and Tsuda 2000; Kumar et al. 2009a). Reversible flows represent fields that are identical on the
inhalation and exhalation portions of the breathing curve. If particles were introduced to a
reversible flow, their path would be overlapping over a given breathing period (same path for
inhalation and exhalation). Sznitman et al. (2007a; 2009), however, reported reversible flow
when the ratio was greater than 0.02. Because the scope of the prior work varies from the
current work, the flow rate ratio will be used to compare the results.

Zones of recirculating eddies exist where flow separation occurs, causing a swirling effect in the
fluid field. Tsuda et al. (1995) and Tippe and Tsuda (2000) presented similar recirculation data
with their joint geometry. Both found recirculation regions where the flow rate ratio was small
(ranging from 0.01 to 0.02 and from 0.02 to 0.06 for Tsuda et al. (1995) and Tippe and Tsuda
(2000), respectively). Both agree, however, that reversible flow is present above a flow rate ratio
of 0.06. Darquenne (2001) and Karl et al. (2004), however, found recirculation in all of their
studied cases. Sznitman et al. (Sznitman et al. 2007a; Sznitman et al. 2009) reported no
recirculation in the terminal sac and the two proximal generations, but found recirculation in
generations 19 and 20. Oakes (2008) found reversible flow in both experimental models for all
of her trials. Similarly, Kumar et al. (2009a) found no recirculation in their terminating sac, but
did, however, find recirculation in the generation immediately proximal.

1.4 – Gaps in the Research
Because in vivo geometry is complex and still not well understood, very few studies research the
differences that exist between healthy and diseased lungs; including varying geometry or flow
rates. Recently, research was compared on the flow fields existing in idealized healthy and
emphysematous lungs (Oakes 2008), while the experimental models were created from idealized
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geometry dimensions (Weibel 1965; Haefelibleuer and Weibel 1988; Klingele and Staub 1970;
Mercer et al. 1987; Kohlhaufl et al. 1997; Kohlhaufl et al. 2000). Similar to previous studies,
however, the geometry used in Oakes (2008) varies significantly from actual in vivo geometry.

The complexity of the experimental and numerical geometries has evolved and more models are
better representing in vivo geometry. Actual in vivo geometry, however, has yet to be
researched. While most research has used breathing curves similar to realistic breathing
conditions, few replicate the in vivo breathing curve. It was shown that the input flow
parameters have a significant impact on the fluid mechanics within the model. Large flow rate
ratios yield radial flows while low ratios show significant recirculation. It is apparent that
geometry representing a diseased alveolar sac has varying fluid mechanics, but radial flow is still
present for a terminating sac.

1.5 – Scope of the Thesis Work
The goal of this research was to aid in the better understanding of the mechanisms that govern
fluid motion and particle transport in the most distal regions of the lung and to compare the
differences that exist between in vivo healthy and emphysematous models. Specifically, the
existence of recirculation regions in each model will be examined experimentally using
stereoscopic particle image velocimetry (stereoPIV) techniques and comparisons between
healthy and emphysemic geometries made. The following aims were completed to achieve these
research goals:

Aim 1 – Create Compliant Hollow Models
Develop two realistic experimental model prototypes (healthy and emphysemic) from in vivo
human geometries and obtain compliant models of both geometries for use in stereoPIV
experiments.

Aim 2 – Develop PIV Setup Capable of 3D Flow Field Analyses
In order to visualize 3D fluid flow in the experimental models, stereoscopic particle image
velocimetry (StereoPIV) techniques were employed.
Develop an experimental setup to accommodate stereoPIV techniques.
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Create a LabVIEW program to monitor and control the expansion and contraction of the
compliant experimental models based on desired input parameters.
Perform a fluid scaling analysis to ensure that the in vivo fluid fields are properly
represented in the scaled experimental models.
Validate the stereoPIV setup by comparing the results of a full experimental analysis of
simple 3D bulb geometry to the results of a CFD analysis.

Aim 3 – Complete StereoPIV Analysis on Healthy and Emphysematous Models
Using the validated setup in Aim 2, healthy and diseased models were analyzed and compared.
Compare geometry differences and how the flow fields are affected.
Analyze experimental and in vivo velocity fields for both models. Compare the
differences that exist between velocity magnitudes and distributions occurring in each model
(for both experimental results and in vivo predictions).
Compare differences that affect particle transport in the flow fields for each model.
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Chapter 2: Model Creation
2.1 – Cast Human Lungs
2.1.1 – Healthy Human
Casting techniques of Phalen et al. (1973) were employed to cast human lungs from a fixed
cadaver obtained through the Biological Sciences Department at RIT. Healthy lungs were filled
with CO2 to remove residual air then pumped with approximately 80 mL of saline to dissolve the
CO2. 10 mL of 310 RTV was then injected into the lung using a syringe pump which forced the
saline to diffuse through the lung membrane. The casted lung was set overnight to cure and
remained exposed to air for two weeks to dry out. Once dried, the lung was soaked in a 4M
NaOH solution for approximately two weeks to dissolve the tissue and expose the in vivo cast.
The left lung of a healthy human (Figure 2.1A) was cast in the posterior and lateral basal sections
of the lower lobe. Sections of these casts were chosen for further analysis based on geometrical
differences and the quality of the cast (Figure 2.1B and Figure 2.1C). Specifically, portions
having air bubbles or truncated regions due to improper flow of casting material were eliminated.

Microscope pictures were taken of each of the pieces to determine which sections would be used
for final reconstruction. Healthy humans typically have alveolar mouth diameters of
approximately 230 to 330 µm (Kohlhaufl et al. 2000) or 292 to 336 µm (Haefelibleuer and
Weibel 1988) and represent defined bulb structures. Our healthy human casts were within this
range, and were measured between 243 and 378 microns. Figure 2.2 represents microscope
images of the two casts obtained from the healthy human. An ideal cast contains no air bubbles
with defined bulb geometry. Based on the quality of the cast, the existence of uniform alveoli,
and the presence of a terminating alveolar sac, the section in Figure 2.2B was chosen as the final
healthy human cast model. The circled section was scanned and used to create the final
experimental healthy model. Observation of the cast indicated that the terminal sac chosen for
analysis was approximately 5 generations distal to the lower left lobar bronchi.
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Piece 1
Piece 2

A

B

C
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Figure 2.1 - (A) Healthy human lung obtained from a fixed cadaver at RIT. (B) Piece 1 and (C) piece 2 from
the lateral basal lobe of the left lung. (D) Schematic representing the casting locations in the healthy human left
lung (Netter 1979).

A

B

Figure 2.2 - Microscope images of (A) piece 1 and (B) piece 2 from the healthy human lung cast (red
lines represent 1 mm). Circled portion was scanned and reconstructed (see section 2.3.1).
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2.1.2 – Emphysema Human
A fixed human lung having characteristics of emphysema (Figure 2.3A) was obtained from the
cadaver lab at RIT and cast using the same techniques used for the healthy human lung (Phalen
et al. 1973). After filling the lung with CO2, approximately 80 mL of saline was pumped in,
followed by 60 mL of 310 RTV. Unlike the healthy lung, two emphysemic lobes were cast.
Figure 2.3B represents the emphysemic cast of the superior lower left lobe, while Figure 2.3C
represents the cast of the anterior portion of the superior division of the upper left lobe.

A

Upper
right
lobar
bronchi
Middle
right
lobar
bronchi
Lower
right
lobar
bronchi

C

B

Upper
left lobar
bronchi
Lower
left lobar
bronchi

D

Figure 2.3 - (A) Human emphysemic lung obtained from the cadaver lab at RIT. (B) Superior lobe cast and (C)
Anterior lobe cast of the left lung. (D) Schematic representing the locations of casting in the human
emphysemic left lung (Netter 1979).

It was determined that pieces obtained from the cast in Figure 2.3C would be used for further
analysis. This was based on the geometrical differences that exist in the section and the overall
quality of the cast. Again, portions having air bubbles or truncated regions due to improper flow
of casting material were eliminated. It was also seen that Figure 2.3B did not contain defined
bulb structures that were desired. This portion represented more of a solid structure; which could
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be an indication of over expanding and over casting, in addition to disease. The chosen piece
(circled region in Figure 2.3C) was then divided into smaller sections for further analysis.
Microscope images of three separate pieces can be seen in Figure 2.4.

A

B

C

Figure 2.4 - (A), (B), (C) Sections chosen for further analysis from the human emphysema lung cast. (B) Section
scanned and reconstructed (see section 2.3.1). (Red lines represent 1 mm). Circled portion represents the final
experimental emphysemic human model section.

Based on the quality of the cast, the existence of large alveoli, and the presence of a terminating
sac, the section in Figure 2.4B was chosen as the final emphysemic human cast model and was
scanned to create the final experimental emphysemic model (circled portion in Figure 2.4B).
Literature cites emphysematous diameters ranging from 430 to 830 µm (Kohlhaufl et al. 2000)
while our model’s average effective airway diameter measures 1556 microns; indicating that our
model was obtained from a severely diseased lung or was over inflated during the casting
process.

2.2 – Obtain Micro-CT Scans of Cast
Micro-CT images were obtained for each of the chosen lung casts to create 3D digital models. A
list of micro-CT vendors and their capabilities can be seen in Table 2.1. Micro Photonics was
chosen for their high resolution scanner and large image size. Each of the models, healthy
(Figure 2.2B) and emphysematous (Figure 2.4B), was sent to Micro Photonics for scanning and
2D images were received three weeks after shipment.
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Table 2.1 - Chosen CT scan vendor (gray) compared to other considered venders.
Vendor

SUNY Upstate

Micro Photonics

Micro Photonics

Scanco Medical

Micro/Nano

Micro

High Resolution
Micro

High Resolution
Nano

High Resolution
Micro

Rates

$258

$400-1000

$1,200

$350

Resolution
(microns)

37

5 to 8

0.4

6

Image Size

3072 x 2048

2k x 2k - 4k x 4k

1280 x 1024

512 x 512 - 4096 x
4096

Image Format

16 bit RAW

n/a

n/a

n/a

8 cm (axial) x 5.4
cm (transaxial)

10mm - 78mm
diameter (width)

1mm maximum
diameter

36 mm max field of
view

5.4 cm (axial) x 8
cm (transaxial)

155mm diameter
(height)

5 mm height

140 mm max length

Scan Dimensions

2.3 – Create 3D Digital Model from 2D Slices
2.3.1 – Reconstruct Whole Model
The entire healthy human cast model
(circled portion in Figure 2.2B) was
reconstructed using the 2D images to
determine a final model location. 3D
Doctor (Able Software: Lexington,
MA) was used to segment and
reconstruct the models. Figure 2.5
shows a single 2D image of the
healthy model with the entire model
region selected. This is the region that
was segmented and reconstructed.
Figure 2.5 - 3D Doctor ROI selected to include the entire model.
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After selecting the whole model region, the images were auto-segmented. This is a process that
fills in the white areas of the image; indicating which boundaries to create. An image threshold
of 45 to 255 was chosen and image smoothing was selected. After successfully segmenting all
of the loaded images, a simple surface rendering was completed and exported as a *.obj file.
VP-Sculpt (Visible Productions; Fort Collins, CO) was used to open and analyze the rendered
3D model. Figure 2.6A represents the original whole healthy human model that was
reconstructed from the healthy cast. From this model, a smaller section was chosen as the final
model (Figure 2.6B).

A

B

Figure 2.6 - (A) Original whole healthy human reconstruction and (B) circled region selected for final model.
(Both reconstructions are shown prior to 2D slice editing)

The same process was used for the emphysemic human model, but the entire model was unable
to be reconstructed at once because of its size; too many facets and vertices. Therefore, prior to
reconstruction, a region of interest was determined by looking at the physical cast. This smaller
selected region was then able to be reconstructed because it contained fewer facets. Figure 2.7A
represents a partial reconstruction of the emphysemic human cast and the section chosen for the
final emphysemic model (Figure 2.7B).
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A

B

Figure 2.7 - (A) Portion of the original emphysemic human reconstruction and (B) circled region selected for final
model. (Both reconstructions are shown prior to 2D slice editing)

2.3.2 – Edit 2D Slices of Final Model Region
Once the final region was chosen, the 2D images were edited for final processing. As seen in
Figure 2.8, holes and major voids were present in the 2D slices. Images were edited in ImageJ
(National Institutes of Health, USA) to remove the presence of holes in the final model. Also,
the edges of the images were cleaned up as to not interfere with the segmentation process.
Editing is a very delicate and tedious process that is extremely time consuming, but is also
necessary to obtain a usable final model. Figure 2.8A represents a single 2D image that required
edits. The holes were filled and the wart like structures removed. Figure 2.8B represents the
same 2D slice after editing.

Warts
Removed

A

Holes
Filled

B

Figure 2.8 - (A) 2D slice showing where edits need to occur and (B) the final edited image.
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Figure 2.9 illustrates the significance of editing the images prior to reconstructing. Figure 2.9A
displays a portion of a reconstruction using original images with no edits. Large holes are visible
and wart like structures can be seen on the surface. Figure 2.9B shows the same reconstruction
region using edited images. It can be seen that the holes are filled and a majority of the warts
removed. The overall quality of the edited reconstruction has drastically increased and is
necessary for obtaining a useable final model.

B

A

Figure 2.9 - (A) Portion of a healthy human reconstruction with circles showing where holes and
wart structures exist and (B) the same reconstruction using edited 2D images.

The 2D editing process described above was applied to all of the images that make up the final
model sections (Figure 2.6B and Figure 2.7B) to create a final reconstruction.

2.3.3 – Process Surface of Final Model
After the final models were reconstructed, VP-Sculpt was used to make final edits (fill holes and
outer boundaries left by 3D doctor, remove improper facets/vertices, etc.) to the surface of the
model and to decrease the number of model facets. This allows the model to be opened in
SolidWorks (Dassault Systèmes SolidWorks Corp.; Concord, MA) where a duct was added.

After all of the holes and boundaries were filled, improper faces and vertices were deleted. The
process of deleting then filling in holes was repeated until holes/boundaries or improper
faces/vertices no longer existed. The model was then smoothed about 50 times using the default
parameters to increase the quality of the surface.
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Figure 2.10 displays the progression of obtaining a final edited 3D digital model from the
original healthy human cast (shown from two different angles) while Figure 2.11 represents the
emphysemic human final model progression. The circled regions represent the portions of the
models chosen for the final experimental models.

Healthy Acinus Cast

VP-Sculpt Digital
Model

Chosen Model Section

Final Smoothed Model

Figure 2.10 - Progression of obtaining a final 3D digital model from the original healthy cast (shown from two
different angles).

Emphysemic Acinus Cast

VP-Sculpt
Digital Model

Chosen Model
Section

Final Smoothed Model

Figure 2.11 - Progression of obtaining a final 3D digital model from the original emphysemic cast.

2.4 – Create Inlet Duct
An inlet duct was added to both of the final models using SolidWorks. In order to open the
model in SolidWorks, it was first decimated multiple times to decrease the number of facets
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(small pieces that make up the surface of the model). A total of four decimations were
completed on the healthy model leaving 27,012 vertices and 54,032 facets (originally368,238
vertices and 736,416 facets). The emphysemic model was decreased to 23,497 vertices and
46,982 facets (originally 1,589,498 vertices and 3,174,083 facets). The healthy model was
imported into SolidWorks as a surface body and an extrusion added based on the surrounding
geometry of the model. Figure 2.12 displays the progression of creating an inlet duct using
SolidWorks for the healthy human model. The circled sections represent the features that were
added at each step.

Figure 2.12 - Process of creating an inlet duct on the healthy human model using SolidWorks.

The newly created duct and features were joined to the existing model and was completed using
VP-Sculpt. A tedious process of moving the duct into place on the healthy model was completed
and is depicted in Figure 2.13.

Figure 2.13 - Progression of translating duct onto healthy human model
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A duct was also created for the
emphysemic model, but further
additions were first required.
Because of the location of the
final model section, portions of
the model were cut from the rest
of the geometry leaving flat
surfaces where material exists
in the whole model. Therefore,
the missing bulb structures were

Figure 2.14 - (Top) Original emphysemic model with the
(Bottom) additions made to fill in voids.

recreated manually (Figure

2.14). Figure 2.15 represents the final healthy and emphysemic models from three different
views. These models were scaled to in vivo dimensions then scaled to the proper experimental
size as described in the following section.

A

B

C

D

E

F

Figure 2.15 - Healthy human final model (A) front, (B) top, and (C) right views (inlet duct measures 113.6
mm prior to scaling). Emphysemic human final model (D) front, (E) top, and (F) right views (inlet duct
measures 290.32 mm prior to scaling).
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2.5 – Scale Model
2.5.1 – In Vivo Size
The final models were first scaled to in vivo dimensions and then scaled to the desired
experimental size (see Chapter 3). Figure 2.16 represents the images of the in vivo models used
for scaling. The yellow lengths represent the known dimensions and the colored lines were then
measured and used for the in vivo scaling. When the final smoothed model sections were first
brought into VP-Sculpt, the dimensions of the model were larger than the desired in vivo or
experimental size (Figure 2.15). Therefore, each colored length in Figure 2.16 was measured on
the over-sized model and compared to the corresponding in vivo dimensions.

Table 2.2 and Table 2.3 represent the measured in vivo and VP-Sculpt dimensions for the colored
lines in Figure 2.16 for the healthy and emphysemic models, respectively.

A

B

Figure 2.16 - Images of (A) healthy and (B) emphysemic models representing dimensions used for in vivo scaling.
The yellow bar in (B) represents 1 mm.

Comparing the VP-Sculpt dimensions to the desired in vivo size, an in vivo scaling factor of
3.61E-3 was used for the healthy human model which yielded an in vivo volume of 1.3 mm3
(0.013 mL) and an in vivo duct diameter of 0.41 mm. The in vivo emphysemic model measured
13.6 mm3 (0.136 mL) with a duct diameter of 0.90 mm (using a scaling factor of 3.06E-3).
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Table 2.2 - Measured in vivo and VP-Sculpt dimensions for the healthy human model shown in Figure 2.16A.
(An average scale factor of 3.61E-3 was used to scale from VP-Sculpt to in vivo size)

In Vivo Dimension

VP-Sculpt Dimension

Scale Factor

Yellow Scale

1 .0 mm

N/A

N/A

Blue Line

0.43 mm

119.6

3.55E-03

Red Line

0.40 mm

113.7

3.51E-03

Green Line

0.25 mm

65.7

3.76E-03

Duct Diameter

0.41 mm

113.6

3.60E-03

Table 2.3 -Measured in vivo and VP-Sculpt dimensions for the emphysema human model shown in Figure 2.16B.
(An average scale factor of 3.06E-3 was used to scale from VP-Sculpt to in vivo size)

In Vivo Dimension

VP-Sculpt Dimension

Scale Factor

Yellow Scale

1 .0 mm

N/A

N/A

Blue Line

2.29 mm

759.67

3.01E-03

Red Line

1.69 mm

552.04

3.06E-03

Green Line

0.98 mm

317.85

3.08E-03

Duct Diameter

0.90 mm

290.32

3.10E-03

2.5.2 – Experimental Size
Experimental parameters for both the healthy and emphysemic models were determined and can
be seen in Chapter 3 (refer to Table 3.2 and Table 3.4, respectively). Both experimental models
have a duct diameter of 8 mm. Therefore, the healthy model was scaled from in vivo size by a
factor of 19.4 to yield an experimental model volume of 9013.5 mm3 (scaled from 0.41 mm to
8.0 mm) The emphysemic model, however, required a scaling factor of 8.9 to obtain a duct
diameter of 8 mm from in vivo size; in vivo diameter of 0.9 mm corresponding to and
emphysemic experimental model volume of 10488.6 mm3.

2.6 – Create Compliant Models
Physical prototypes of both of the experimental healthy (19.4x in vivo size) and emphysemic
(8.9x in vivo size) models were obtained from Laser Reproductions (Gahanna, OH).
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Specifically, each of the models was rapid prototyped using stereolithography techniques at a
layer resolution of 0.006” and coated with a semi-bright nickel finish. The finish is necessary to
create a surface on the prototype that does not degas into the compliant dipping material. This
reduces the creation of bubbles in the compliant model and minimizes the amount of laser light
refraction. The healthy human prototype (Figure 2.17) measures 33 mm in length and 41 mm in
width while the emphysemic prototype measures 31 mm long and 35 mm wide (Figure 2.18).

A

B

D

C

Figure 2.17 - Healthy human physical prototype model (A) top, (B) bottom, (C) left, and (D) right views.

A

B

C

Figure 2.18 - Multiple views of the emphysemic human physical prototype model.

Each of the physical prototype
models were then dipped into a bath
of melted Ultraflex (Douglas and
Sturgess Inc.; Richmond, CA) and
quickly removed. To ensure
uniform thickness throughout the
compliant model, the models were

Figure 2.19 - Compliant experimental model of the healthy human lung.
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rotated once removed from the bath. After completely cooled (waiting approximately ten
minutes), the Ultraflex model was removed from the solid prototype. Figure 2.19 and Figure
2.20 represent images of the healthy human and emphysemic human compliant experimental
models, respectively.

When creating future prototypes, it is important to have a thick coating of nickel applied as to
reduce the possibility of
cracking. Because the SLA
material is not rated for the
high melting temperatures it is
exposed to, allowing the
prototype to completely cool in
between each dip is essential to
maintaining a useable
prototype model.

Figure 2.20 - Compliant experimental model of the emphysemic human lung.
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Chapter 3: Flow in the Experimental Model
3.1. – Theory
The incompressible, constant viscosity Navier-Stokes equations (White 2006) can be written in
non-dimensional form as

fd

2

u

Ud

u

Ps d

u

u /U

,

*

d

2

u

U

t

where u *

P

, P*

P / Ps , t*

tf

(3.1)

, Ps is an arbitrary value chosen to balance the

viscous term, ρ is density, u is velocity vector, t is time, P is pressure, µ is dynamic viscosity, f
represents the breathing frequency (breaths/sec), d is duct diameter, and U is the time and
spatially averaged inlet velocity. The first dimensionless term in Equation 3.1 is related to the
Womersley number, the ratio of oscillatory inertial to viscous forces (Loudon and Tordesillas
1998; Womersley 1955), by

Wo

d

f

2

(3.2)

where ν is the kinematic viscosity of the fluid. The second dimensionless term represents the
time averaged Reynolds number ( Re

Ud

), the ratio of inertial forces to viscous forces, and

can be written in terms of the experimental conditions as

Re

4 fEV i
d

(3.3)

where E is percent expansion and Vi is initial model volume. Because the experimental models
were scaled up from the in vivo size, the experimental parameters were derived as to match both
the in vivo Re and Wo to the experimental Re and Wo , respectively, for both the healthy and
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emphysemic models. Based on fabrication techniques, however, an 8 mm model diameter was
desired for both of the models. Therefore, the other parameters affecting the Re and Wo were
varied to properly match the in vivo conditions

3.2 – Convergence of Small Wo and Re
It is well understood that for small Re and Wo, non-dimensional velocity profiles are
independent of Re and Wo, respectively. To test the limits of this assumption, a computational
fluid dynamic analysis was run on the expanding three dimensional bulb used for experimental
validation seen in Figure 3.1A (Berg et al. 2010). After verifying a grid independent solution,
the non-dimensional profiles were obtained numerically for successively small Wo and Re using
Fluent (Fluent, Inc.) at two locations in the model; in the center of the rigid duct at z = 0.55 mm
and in the expanding bulb at z = 0.375 mm (Figure 3.1).

Figure 3.1 - Velocity profiles for varying Wo occurring (A) in the expanding bulb at z = 0.375 mm and (B)
in the rigid duct at z = 0.55 mm. Velocity profiles for varying Re occurring (C) in the expanding bulb and
(D) in the rigid duct.
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Figure 3.2 shows that non-dimensional velocity profiles converge at about Wo = 0.2 and Re =
0.7, which are both larger than the in vivo and experimental conditions in the present study.
These results were used to insure that in vivo conditions were well represented experimentally, as
explained in the following sections.

Figure 3.2 - Convergence plots for (A) Womersley and (B) Reynolds numbers showing that velocity profiles
converge prior to reaching the maximum experimental Wo = 0.07 and before the maximum experimental Re = 0.24.
NL refers to the non-dimensional locations in Figure 3.1.

3.3 – Healthy Human Parameters
Table 3.1 represents the model and material properties for the healthy human model used for
experimental analysis. These values were concluded from the scaling analysis described in
Chapter 2. The experimental healthy model was scaled from the in vivo size by a factor of 19.4
to obtain a duct diameter of 8 mm.

Table 3.1 - Model and material properties for the healthy human model.

Symbol
d

Property
Acinus Inner Duct Diameter

In Vivo

Experimental

(Air at 20°C)

(Glycerin at 20°C)

0.41

8.00

1.25

9013.46

17.10

909.80

(mm)

Vi
ν

Mean Acinus Volume
(mm3)

Kinematic Viscosity
(mm2/sec)
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In vivo breathing conditions for a healthy human breathing under normal conditions were
determined based on information cited by Robinson et al. (2007). Using an average functional
residual capacity (FRC) of 3050 L and an average tidal volume (TV) of 483 mL, the calculated
in vivo expansion (TV / FRC) is 16% with an average breathing frequency of 15.71 breaths/min.
Using the properties in Table 3.1, the in vivo Re is 0.009 with a Wo of 0.03. To simulate heavy
breathing for a healthy human, however, Re and Wo were calculated using 60% expansion and
found to be 0.04 and 0.03, respectively (Table 3.2). Because both Re and Wo are small and less
than the converged values of 0.7 and 0.2, respectively (section 3.2), this indicates that the flow
fields in the alveoli region are unchanged for normal versus heaving breathing conditions in a
healthy human.

In order to match the experimental parameters with the in vivo conditions used in this work, the
Wo was first matched because it is only a function of the breathing frequency; assuming the
diameter is fixed at 8 mm (Equation 3.2). For an in vivo Wo of 0.03, an experimental breathing
frequency of 2.23 breaths/min was required (a period of 26.9 seconds). Using this required
frequency, an experimental expansion of 16% would then match the in vivo Re (Equation 3.3).
The calculated in vivo and experimental flow parameters are shown in Table 3.2.

Table 3.2 - Healthy human in vivo and experimental fluid parameters required to match Re and Wo.
The grey values represent the chosen parameters used in this work.

In Vivo
Air at 20° C

Experimental

Breathing
Frequency
(breaths/min)

Period
(sec)

Womersley

Expansion
(%)

Reynolds

Normal Breathing

15.7

3.8

0.03

16

0.009

Heavy Breathing

15.7

3.8

0.03

60

0.035

Matched Normal

2.2

26.9

0.03

16

0.009

Matched Heavy

2.2

26.9

0.03

60

0.035

Used in This Work

15.0

4.0

0.07

35

0.138

Glycerin at 20° C
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It is seen that the experimental period required to precisely match in vivo conditions is extremely
large (26.9 seconds for a single breath to be completed). This is not an ideal condition because
the particle displacements between sequential images would be difficult to detect. Also, because
the motion of the pump would have to be extremely slow to produce a 26.9 second breathing
period, we did not want to introduce residual particle motion into the system between sequential
frames. Therefore, a more realistic breathing period for experiments is 4 seconds.

If a 4 second period was used rather than 26.9 seconds, the corresponding Wo is calculated to be
0.07 with a Re of 0.14 (using an expansion of 35%), which is still small and less than the
converged values of 0.2 and 0.7, respectively. It is clear from the velocity profile plots (Figure
3.1) that the in vivo conditions for both Re and Wo would be met for all proposed experimental
healthy cases because the non-dimensional velocity profiles are identical for Womersley
numbers of 0.03 and 0.07, and for Reynolds numbers of 0.02 and 0.20 (within the range of
proposed experimental conditions). Therefore, the presence of heavy breathing conditions has
little effect on the flow field.

The grey values in Table 3.2 represent the final experimental Re and Wo using a breathing
period of 4 seconds as compared to the in vivo Re and Wo. A 35% expansion was desired for the
healthy model because the corresponding average input flow rate of 1.9 mL/sec coupled with the
chosen pulse frequency of the laser (12.5 Hz) yields the appropriate particle displacement for
collected image pairs.

3.3 – Emphysemic Human Parameters
Using the desired experimental duct diameter of 8 mm for the emphysemic model, a scaling
factor of 8.9 was applied to the in vivo model (see Chapter 2). The model and material properties
for the in vivo and experimental emphysemic models are shown in Table 3.3

In order to apply the same flow conditions to both the emphysemic and healthy models, the Re
and Wo between each model were matched (Re = 0.14 and Wo = 0.07). In order to achieve
these values, an experimental expansion of 30% was required for the emphysemic model with a
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breathing period of 4 seconds (the difference in experimental percent expansion is due to the 11x
difference in initial volumes between the healthy and emphysemic models).

Table 3.3 - Model and material properties for the emphysemic human model.

Symbol
d

In Vivo

Experimental

(Air at 20°C)

(Glycerin at 20°C)

0.90

8.00

14.39

10488.60

17.10

909.80

Property
Acinus Inner Duct Diameter
(mm)

Vi
ν

Mean Acinus Volume
(mm3)

Kinematic Viscosity
(mm2/sec)

Table 3.4 - Emphysemic human in vivo and experimental fluid parameters required to match Re and Wo.
The grey values represent the chosen parameters used in this work.

In Vivo

Breathing
Frequency
(breaths/min)

Period
(sec)

Womersley

Expansion
(%)

Reynolds

Normal Breathing

16.0

3.7

0.03

11

0.04

Matched Normal

2.3

26.4

0.03

50

0.04

Used in This Work

15.0

4.0

0.07

30

0.14

Air at 20° C

Experimental
Glycerin at 20° C

The chosen experimental parameters for the emphysemic model are shown in grey in Table 3.4.
Similar to the healthy model, an inlet flow rate of 1.94 mL/sec was applied to the emphysemic
model. It is seen that the chosen experimental parameters (Re = 0.14 and Wo = 0.07) are below
the converged values of Re = 0.7 and Wo = 0.2 (see section 3.2). Therefore, the presence of
emphysemic conditions plays little to no role in alveolar flow. This allowed us to focus solely on
the differences in flow fields that exist between the healthy and emphysemic models due to
geometry effects rather than input Re or Wo (for all values of Re ≤ 0.7 and Wo ≤ 0.2).
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Chapter 4: Experimental Methods
4.1 – StereoPIV Theory
PIV is an optical measurement technique used to non-invasively obtain instantaneous velocity
fields in fluid flows. The fluid is seeded with small reflective tracer particles whose motion is
tracked between images. Stereoscopic PIV is based on the same fundamental principles as
human eye-sight. As with 2D measurements, stereoPIV measures displacements rather than
actual velocities (with the cameras playing the roles of the eyes). The most accurate
determination of the out-of-plane displacement is accomplished when there is 90° between the
two cameras. The first camera would be able to capture the x and y components of velocity,
while the second camera would capture the y and z components. In the cases of restricted optical
access, however, smaller angles can be used at the cost of a somewhat reduced accuracy. For
each vector, three true displacements (dX, dY, and dZ) are extracted from a pair of 2dimensional displacements (dx, dy) as seen from the left and right cameras, respectively. Figure
4.1 illustrates the fundamentals of the stereoPIV process. The blue arrow, for example, would
represent a single particle displacement through the light sheet. The 2D particle displacement
seen from left camera is shown as the red arrow, while the 2D particle displacement seen from

Z direction

the right camera is represented as the black arrow.

X direction
Figure 4.1 - Fundamentals of stereoPIV (Dynamics 2010). The x and z directions are
depicted as right and up, respectively, while the y direction is out of the plane.
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Due to perspective distortion
occurring from the angle of the
cameras with respect to the light
sheet, each camera covers a
trapezoidal region of the light sheet.
Even with careful alignment of the
two cameras, their respective fields of
view only partly overlap each other.
Within the region of overlap,
interrogation points are chosen in a
rectangular grid to match the spatial
resolution of the cameras (Figure 4.2).

Left Camera 2D Vector Map

Figure 4.2 - Overlap area with interrogation region resulting from each
cameras field of view (Dynamics 2010).

Right Camera 2D Vector Map

The actual stereoscopic
measurements begin with
conventional 2D PIV processing of
simultaneous recordings from left
and right cameras, respectively.
This produces two 2-dimensional
vector maps representing the

Figure 4.3 - Processed 2D vector maps from each camera
(Dynamics 2010).

instantaneous flow field as seen

from the left and right cameras, respectively (Figure 4.3).

The acquired images are grey scale images with variations of light intensities representing the
presence of fluorescent particles. Each image set (two sequential image pairs) is separated by a
known deltaT, the separation between laser pulses, and broken into small interrogation regions
for cross correlation. Figure 4.4 represents a typical interrogation region used for image
processing (representing 32x32 pixel squares). The group of particles that exists in each
interrogation region represents a fairly unique ‘fingerprint’ that is tracked between both frames
in the image set. Once a unique pattern is found for a particular region, the mask is scanned
through the defined search area in the second frame and a correlation value is calculated at each
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position. The value of the correlation function will be
maximized when the ‘fingerprint’ is identified in the mask
in the second frame. Ideally, a single, distinct, round peak
will exist in the correlation map. Once identified, the x
and y displacements of the particles are determined by the
offset of the interrogation regions. Finally, since the
deltaT between laser pulses is known, the group velocity
for a particular region is measured as the displacement
divided by the deltaT, and a single vector is assigned for

Figure 4.4 - Typical interrogation region
used for image processing.

each interrogation region (Figure 4.5). The process is completed for every interrogation region
until all vectors are calculated (either real or interpolated). Figure 4.6 illustrates a different
perspective on the calculation of a velocity vector for a particular interrogation region.

A

B

C

Figure 4.5 - (A) Identify particle mask, (B) determine position change, and (C)
calculate vector based on known displacement / known deltaT (TSI 2009).

Figure 4.6 - Image processing theory representing a single correlation peak
(LaVision 2009).
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Using the known parameters from the perspective
calibration (distance from the object to the image,
lens focal length, and camera angle), the points in
the interrogation grid (overlap area occurring in
Figure 4.2) are mapped from the light sheet plane
onto the left and right image planes (camera sensor)
respectively. The 2D vector maps are re-sampled
in the new interrogation regions to estimate 2D

Figure 4.7 - Resulting 3D vector map
(Dynamics 2010).

vectors at each point based on the nearest neighbours. The resulting 3D vector map is then
calculated and depicted in Figure 4.7.

4.2 – Experimental StereoPIV Setup
4.2.1 – Cameras and Optics
The experimental setup developed in our lab for stereoPIV analysis is shown in Figure 4.8.

Figure 4.8 - Experimental stereoPIV setup developed in our lab.

Images were captured using two IDT Motion Pro X-3 Plus high-speed digital cameras, each
equipped with a Tamron macro lens with a focal length of 90 mm, f-number of 2.8, and an image
macro magnification ratio of 1:1. Ideally, Scheimpflug mounts are used to focus on planar fields
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at oblique viewing angles. Because they were not used in this experiment, the camera angles
were minimized to allow the entire image to be in focus across the laser sheet. Therefore, each
camera was angled 15° from the perpendicular to the light sheet and was 7” from the center stand
(30° between cameras as opposed to the ideal angle of 90° as described above). The distance
from the camera lens to the experimental model was chosen as to allow the entire experimental
model to fit into the field of view of each camera, resulting in a spatial resolution of 64.23 µm
per pixel occurring at the center of the experimental setup and varying as the light sheet location
changes. The fluid was illuminated with a New Wave Research Solo II pulsed 532 nm laser and
8 µm red fluorescent polymer microspheres (Duke Scientific Corp.; Palo Alto, CA) were used as
tracer particles in 99% glycerin carrier fluid (emitting at 612 nm). A mirror, positioned on a
rotation stage, was used to direct the beam from the laser to the optics. A planar laser sheet was
created by passing the collimated laser beam through a cylindrical lens, focal length of 25.4mm,
and a spherical lens of focal length 150 mm. The cameras were focused on regions of the
experimental models in which the laser sheets waist (focal point of the beam) occurred,
measuring approximately 1 mm thick and occurring in the center of the model. The cameras and
laser were synchronized using a TSI Laser Pulse Synchronizer and triggered with the start of
each experiment.

4.2.2 – Testing Fixture and Components
The experimental testing rig (shown in Figure 4.8) was developed to contain the experimental
models and to simulate the input breathing parameters to achieve the proper in vivo flow
conditions. Each compliant model was housed in a glycerin (refractive index of 1.47 ± 2.0E-3)
chamber and filled with a glycerin / particle mix of approximately 0.007 grams of particles per
150 mL of glycerin to achieve the appropriate mixture required to minimize PIV processing error
(Soria 2000). A computer controlled syringe pump drew a negative pressure on the chamber
fluid, expanding the model and drawing glycerin from the inlet tube into the compliant model.
Total model volume changes were verified with pressure sensors placed at the model inlet
(MPXV5010GP, Freescale Semiconductor, Inc.) and at the base of the chamber (PX2300-10DI,
Omega Engineering, Inc.). The syringe pump (NE-500, New Era Pump Systems, Inc.) was fitted
with a stepper motor and controlled by a motion controller (MBC25081TB, Anaheim
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Automation), programmed using LabVIEW and a DAQ device (PCI-6025E DAQ, National
Instruments Corp.).

4.2.3 – LabVIEW Code
A LabVIEW code was generated to accurately control the motion of the experimental models
based on the in vivo flow conditions. Once the experimental parameters were chosen (Chapter
3), the Re and Wo were matched by varying the input controls (initial model volume, percent
expansion, and breathing period). Figure 4.9 represents the LabVIEW block diagram used to
expand and contract the experimental models.

Figure 4.9 - LabVIEW block diagram used to expand and contract the experimental models.

Based on the initial volume and percent expansion of each model, the total volume change was
calculated and converted to a linear distance based on the area of the syringe used (140 mL
syringe with a cross sectional area of 1.7203 in2). The average linear distance moved per step of
the motor was 6.2E-5 in. Therefore, the total number of steps and step frequency (number of
steps / inhalation time) was calculated and applied to the stepper motor. Each model required a
flow rate of 1.94 mL/sec for a 4 second period (see Chapter 3) corresponding to a 3.15 mL
volume change over the inhalation time (1.62 seconds). Therefore, for each model, a total of
1,802 clicks were required at a frequency of 1,112 clicks / second. At the start of the motion of
the pump, a 5V trigger was sent to the pulse synchronizer to begin image capture. Finally, data
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from the pressure sensor located at the inlet to the model was sampled and displayed to verify the
correct volume change during each experiment.

4.3 – Image Capture
TSI’s Insight 3G (TSI Inc., Shoreview, MN, USA) was used to capture images for each
experiment. Figure 4.10
represents the capture settings
used for each of the
experimental models. A
single pulse / frame for each
camera was used with a
frequency of 12.5 Hz (deltaT
of 0.08 seconds between
sequential laser pulses and

Figure 4.10 - Capture settings for stereoPIV experiments.

images). Because a period of 4 seconds was chosen for each model, a total of 50 images were
required for each data set, but a total of 75 images were actually collected to account for any
residual fluid motion. Because two cameras were used, 75 images were collected for the left
camera and 75 collected for the right (a total of 150). For each laser sheet location, a total of
three data sets were collected to illustrate the repeatability of the experimental results (refer to
section 5.2.5 for variability analysis).

4.4 – Healthy Human Analysis Settings
A total of fourteen laser locations were selected for the healthy human model. The laser sheet
was initially positioned just inside the model then moved in 3.2 mm (1/8”) intervals, collecting
data at every new sheet location. At every position, the distance from the object to the image
was measured (distance from the light sheet to the CCD array in the camera). This information
was necessary to create an accurate perspective calibration file needed for image processing. In
order to achieve the correct in vivo flow conditions (refer to Chapter 3), the input parameters
shown in Figure 4.11 were applied at each laser plane location (breathing period of 4 seconds
and model expansion of 35%).
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Figure 4.11 - LabVIEW output for a healthy human experiment displaying the input parameters
required to match in vivo conditions (4 second period and 35% expansion resulting in an inhale
flow rate of 1.94 mL/sec).

Table 4.1 represents the measurements collected for each laser sheet location where data was
analyzed, including the two regions where recirculation would be most likely to occur.

Table 4.1 - Measurements obtained for each laser sheet location analyzed (RR = recirculation region).

Mirror Location (mm)

Distance Object to Image (mm)

2ndLocation

43.7

669.9

4thLocation

50.0

663.6

56.4

657.2

62.7

650.9

10thLocation

69.1

644.5

12thLocation

75.4

638.2

6thLocation
(1st RR)
8thLocation
(2nd RR)
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4.4.1 – Creating Calibration Files
Insight 3G was used to process the raw images collected from each laser sheet location. First, a
perspective calibration file was created for each location. This allows the program to account for
the magnification changes that occur across the field of view of the camera with respect to the
center of the light sheet. Figure 4.12 represents the left and right calibration files for the second
location in the healthy human model.

A

B

Figure 4.12 - (A) Left and (B) right perspective
calibration files for the 2nd location in the healthy
healthy human model.

Figure 4.13 - Pixel to length conversion
for the 2nd location created from the
information in Figure 4.12.

4.4.2 – Stereo AutoMapping
Prior to processing the raw images, it was important to translate the images to make sure they
were on top of each other.
Figure 4.14 represents an image
pair prior to translating with a
blue grid overlaid representing
50 pixels per square. It can be
seen that Figure 4.14B needs to
be translated approximately 100
pixels to the left and 10 pixels
down to align with Figure
4.14A. This translation was

A

B

Figure 4.14 - Images prior to translating (grid represents 50 pixels).
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completed using ImageJ and was necessary for all image sets analyzed. A stereo AutoMapping
procedure was then completed on all selected laser sheet locations to optimize the perspective
calibration by correcting the misalignment errors existing in the measurements between the light
sheet location and the CCD array in the camera. This procedure was completed for each location
to update the manual calibration files. A series of AutoMapping iterations was performed (as
defined in the Insight 3G manual) until the parameters were considered converged and the final
pixel to length conversion factor calculated. Figure 4.15 represents the results of the stereo
AutoMapping procedure for the 2nd laser sheet location in the healthy model. It is seen that after
the 4th iteration, the parameters have converged with the number of valid vectors maximized.

Figure 4.15 - Stereo AutoMapping results for the 2nd location in the healthy model.

A
Figure 4.16 - Perspective calibration for the
2nd location after stereo AutoMapping.

B

Figure 4.17 - Processing mask for the (A) 4th and (B) 6th
locations in the healthy model.

Based on the stereo AutoMapping results, the perspective calibration files were updated. Figure
4.16 represents the updated calibration file that was used for processing the 2nd location images.
It can be seen (when compared to Figure 4.13) that the linear conversion factor increased from
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60.07 µm / pixel to 60.18 µm / pixel in (shown in the red boxes from Figure 4.13 to Figure 4.16)
and is used when converting the particle displacements from pixels to physical length. This
small change in conversion factors is an indication that the measurements obtained from the
setup used to create the initial perspective calibration were correct. Each location also requires a
unique processing mask. This determines which regions of the raw images to analyze. Vectors
outside of the physical model are of no interest, and, to reduce processing time, are not included
in the processing. Therefore, at each location, an outer boundary is drawn on the raw images to
represent which regions to process. As an example, Figure 4.17 illustrates the processing mask
applied at two different locations (shown as the dotted lines).

4.4.3 – StereoPIV Processing Parameters
With the AutoMapping completed with the
final conversion factor calculated (Figure
4.16) and processing mask applied, each of
the laser locations were then processed to
extract particle displacements and velocity
vectors. A correlation based PIV processor
algorithm (Insight 3G default) was used to
analyze the image pairs. A recursive
Nyquist grid engine was chosen to increase

Figure 4.18 - StereoPIV processor used for image processing.

the accuracy and spatial resolution of the results by processing the images in two passes with
50% grid overlapping. The correlations were calculated using Fast Fourier Transforms (FFT)
while the correlation peaks were located by
fitting a Gaussian curve to the highest pixel
and its four nearest neighbors. Figure 4.18
shows the stereoPIV processor setup used for
the healthy human model, while Figure 4.19
represents the post processing parameters

A B
Figure 4.19 - (A) Local vector validation parameters and
(B) vector conditions parameters for processing.

used for analysis. With all of the necessary
parameters defined, each image set was
analyzed using a known deltaT of 0.08
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seconds (pulse frequency of 12.5 Hz). Results for the healthy model are found in Chapter 6.

4.5 – Emphysemic Human Analysis Settings
A total of twelve data laser sheet locations were selected for the emphysemic human model. The
laser sheet was initially positioned just inside the model then moved in 3.2 mm (1/8”) intervals,
collecting data at every new sheet
location. Similar to the healthy
model, the distance from the
object to the image was measured
at every laser location and used to
create a unique perspective
calibration file for every distance
(distance from the light sheet to
the CCD array in the camera).

Figure 4.20 - LabVIEW output for an emphysemic human experiment
displaying the input parameters required to match in vivo conditions (4
second period and 30.08% expansion resulting in an inhale flow rate of
1.94 mL/sec).

Figure 4.20 illustrates the flow conditions applied to the emphysemic model at every sheet
location to match the in vivo flow conditions (4 second breathing period and expansion of 30%).

Table 4.2 shows the measurements obtained for each of the laser sheet locations analyzed. The
process described in section 4.4.3 for processing of the healthy images was applied to the
emphysemic model while the emphysemic model results are found in Chapter 6.

Table 4.2 - Measurements obtained for each laser sheet location analyzed for the emphysemic model.

Mirror Location (mm)

Distance Object to Image (mm)

2ndLocation

73.8

639.8

4thLocation

67.5

646.1

6thLocation

61.1

652.5

8thLocation

54.8

658.8

10thLocation

48.4

665.2
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Chapter 5: Experimental Validation
5.1 – CFD Expanding Boiling Flask Model
In order to validate the experimental stereoPIV setup, a simplified geometry was first tested
experimentally and compared with computational results.

5.1.1 – Model Creation
A boiling flask model was created in SolidWorks

A

B

using the outer dimensions of a 50 mL glass
boiling flask (Figure 5.1). The two vertical blue
lines in the model represent the different planes
that were analyzed. The first plane (plane that the
laser sheet goes through in the model) was
located in the center of the model, while the
second plane was 11 mm from the center.

Figure 5.1 - (A) Glass boiling flask and (B) SolidWorks
model used for CFD simulations.

5.1.2 – Fluent Simulation

5.1.2.1 – Input Parameters
A constant flow rate of 3.20 mL/sec was applied to the model for 2.5 seconds. This represents
an 8 mL increase in volume corresponding to 9.5% expansion of the model. These conditions
were chosen to allow for proper expansion of the bulb model mesh. Because portions of the
mesh were stationary throughout the simulation while other regions were continually expanding
and changing positions, the risk of overlapping of the mesh existed, which would cause failure of
the simulation. For this boiling flask mesh, a percent expansion of ≤ 16.5% was desired to
prevent overlapping or negative volume detection in the model. Therefore, an arbitrary
expansion of 9.5% was chosen.

A 3D, unsteady, pressure based solver was used in Fluent to simulate the boiling flask model.
Glycerin was defined as the fluid material with a density, ρ, of 1264.02 kg/m3 and a dynamic
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viscosity, µ, of 1.15 kg/m-s. Three dynamic zones were defined for the bulb: the inlet (stationary
top surface of the duct where the inlet flow rate was applied), a moving zone (all nodes making
up the circular geometry of the bulb where expansion of the nodes occurs (shown as the blue
portion of the model in Figure 5.1B)), and a deforming zone (portion of the model that connects
the stationary inlet to the moving boundary (shown in grey in Figure 5.1B)). The motion of the
moving boundary zone was defined in the user-defined function (UDF). The model was remeshed in-between each iteration to minimize skewness of the elements and to allow the mesh to
update to the moving contours of the model. A second order upwind scheme was used to
interpolate the momentum term while a second order scheme was selected for the pressure terms.
A PISO algorithm was used for the pressure correction. Under-relaxation factors of 0.2, 0.8, 0.8,
and 0.5 were chosen for pressure, density, body forces, and momentum, respectively, to aid in
the convergence of the solution. In order to check convergence of the fluids equations, residuals
(continuity, x-velocity, y-velocity, and z-velocity) were monitored with a convergence criterion
of 1E-4. Finally, a time step of 0.01 seconds was applied for 250 steps with a maximum of 1000
iterations per time step and the solution was saved at each flow time occurring throughout the
simulation (every 0.01 seconds).

5.1.2.2 – Fluent UDF
In order to expand and contract the boiling flask model in Fluent, similar to the motion existing
in the experimental setup, a UDF (user-defined function) was modified from a previous version
presented by our group (Harding and Robinson 2010). The solution was initialized which reads
the input flow rate array file (constant flow rate of 3.20 mL/sec) and calculates the initial volume
of the model. The grid motion routine starts, which updates the volume of the mesh by iterating
until the correct expanded volume (also known as the target volume) is met. This procedure
calculates the target volume of the model based on the input flow rate and the current time step.
The model is then uniformly deformed in small increments until the percent difference between
the current volume and the target volume is less than 1E-5. This is done by moving all of the
nodes in the moving boundary zone adjacent to the surface the same calculated amount.
Specifically, the nodes are displaced by ((target volume – current volume) * 1E-6) m every
iteration within each time step until the model has expanded to the calculated target volume for
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the given time step. Once the grid has been updated to the calculated target volume for a
particular time step, the Navier-Stokes and continuity equations are solved using an iterative
process. A maximum of 1000 iterations occur until the solution is converged for a given time
step; occurring when the residuals reach 1E-4 (continuity, x-velocity, y-velocity, and z-velocity).
For the physical times analyzed, all velocity profiles were converged in less than the 1000
allowable iterations. An end routine is then completed to append all important data to text files.
This includes the target and current volumes, residuals, and the volume and mass flow rate data
for the given time step. The flow time is then increased by the time step (0.01 was used for this
analysis) and the grid motion routine is restarted followed by the fluid solutions. The above
iterative process of grid motion and fluid solutions is then continued until all of the specified
time steps have been completed. Figure 5.2 represents a flowchart of the UDF that was written
to expand and contract the boiling flask model.

Compile UDF

Fluent Process
Define in Fluent:
Solver
Material Properties
Operating Conditions
Boundary Conditions
Dynamic Mesh
Solution Controls
Residual Monitors

UDF Process
Start Initialization

Read Input Flow
Rate

Define Time Step and
Max Iterations

Start Iteration
Calculate Initial Volume
Update Mesh
(Grid Motion Routine)

Calculate Target
Volume

End Initialization
Uniformly Deform Mesh

No

Calculate
Current Volume

Target Volume Met?
Yes

Increase Flow Time by
Time Step

Iterate Fluids Equations

No

Max Iterations?
No

Convergence Met?

No

Yes
Yes

End Routine

Max Time Steps?

Append Data to File

Yes

Solution Complete

Figure 5.2 - Flowchart of UDF written to expand and contract boiling flask model.
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5.1.3 – Mesh Independence
In order to determine the proper mesh size for CFD simulations, a mesh independence study was
completed on various grid sizes. The six different base mesh parameters that were created in
Harpoon (Sharc Ltd., Manchester, UK) are shown in Figure 5.3. The number of cells in the
mesh models ranged from 32,253 (for a base of 1.4) to 95,762 cells (for a base of 0.85). Each
mesh was created with hex dominant element types.

Figure 5.3 - Various base meshes created in Harpoon.

Each of the six meshes was simulated in Fluent using the same flow conditions described in
5.1.2.1 The code used to simulate the expanding bulb is described in Section 5.1.2.2.

To check grid independence of the velocity profiles occurring throughout the model, velocities
were extracted along two locations in the bulb for each mesh size. The top rake (line at which
velocities are extracted at uniform intervals) was taken in the stationary duct (at y = 54.5 mm
from the bottom of the bulb), while the second rake was extracted in the expanding bulb at the
location of the diameter (at y = 26.8 mm from the bottom of the bulb). The normalized velocity
profiles at both rake locations for all six meshes can be seen in Figure 5.4.
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A

B

Figure 5.4 - Velocity profiles at time = 1.0 second for varying base level meshes occurring (A) in the stationary duct
(y = 54.5 mm) and (B) in the center of the moving wall bulb (y = 26.8 mm).

It can be seen in Figure 5.4 that the velocity profiles are grid independent for mesh base levels
less than or equal to 1.0. The red triangles (mesh = 0.85), black circles (mesh = 0.90), and black
dotted line (mesh = 1.0) are overlapping; representing a grid independent solution. Therefore, a
mesh size of 0.90 was chosen for final analysis and is shown in Figure 5.5 (see Figure 5.3 for the
chosen mesh properties).

A

B

C

Figure 5.5 - (A) Harpoon 0.90 base level mesh of the bulb. (B) Top mesh view of a cross section of the center of the
model and (C) side view of the center cross section of the model.

5.1.4 – CFD Results
An arbitrary flow time of 1.0 second was chosen to compare CFD to experimental results
(corresponding to the 100th CFD case file when using a time step of 0.01 seconds). As described
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above, two plane locations were chosen for analysis. In each plane, the velocity profiles were
compared at two rake locations. The top and bottom rakes were taken 13.4 mm and 3.4 mm
above the location of the diameter of the bulb, respectively, for both the 1st and 2nd plane
locations (Figure 5.6).

A

B

C

Figure 5.6 - (A) View representing both laser sheet planes, (B) view displaying the two rake locations, and (C) front
view of the model showing all four rake locations.

5.1.4.1 – 1st Location – Center Plane of Bulb
Figure 5.7 represents the Fluent grid displaying the
locations of the top and bottom rakes for the 1st location
plane (occurring in the center plane of the bulb). An
evenly spaced rake of 20 data points was extracted for
both the top and bottom rakes. The CFD velocity profiles
corresponding to the 1st location (center plane of the bulb
model) top and bottom rakes can be seen in Figure 5.8
(for a flow time of 1.0 second). The positions (x-axis)
were normalized to allow for comparison between the
CFD and experimental results.

Figure 5.7 - Fluent grid showing top and
bottom rakes.

For comparison, a second flow time of 0.5 seconds was analyzed for the same rake locations as
specified above. The velocity fields occurring at this time for the 1st location can be seen in
Figure 5.9. It is noted that the velocity magnitudes vary only slightly from time = 0.5 seconds to
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time = 1.0 second. Because the model is expanding 9.5% over 2.5 seconds, the extents and
dimensions of the bulb are changing by very small amounts throughout the expansion.
Therefore, at a given rake location (constant y location from time = 0.5 seconds to time = 1.0
second), the extents of the bulb change slightly from 0.5 seconds to 1.0 second, and the velocity
magnitudes remain similar between the two times (an average of 3.5% difference in magnitude
between the top rake of time = 1.0 second and the top rake of time = 0.5 seconds and an average
of 2.4% difference between the bottom rake of time = 1.0 second and the bottom rake of time =
0.5 seconds).

A

B

Figure 5.8 - Velocity profile plots at the 1st location (center plane of the bulb) for the (A) top rake (y = 13.4 mm
above the diameter) and (B) bottom rake (y = 3.4 mm above the diameter) for time = 1.0 second.

A

B

Figure 5.9 - Velocity profile plots at the 1st location (center plane of the bulb) for the (A) top rake (y = 13.4 mm
above the diameter) and (B) bottom rake (y = 3.4 mm above the diameter) for time = 0.5 seconds.
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5.1.4.2 – 2nd Location – 11 mm from Center Plane of Bulb
A second laser sheet location was chosen 11 mm offset
from the center plane of the bulb for further validation
(Figure 5.6A). Figure 5.10 shows the Fluent grid
corresponding to the 2nd location where the top and
bottom rake locations are visible (occurring at y = 13.4
mm and y = 3.4 mm above the diameter, respectively).
The CFD velocity profiles corresponding to the 2nd
location and a flow time of 1.0 second can be seen in
Figure 5.11. Similarly, the Fluent results for the 2nd
location occurring at a flow time = 0.5 seconds are shown
in Figure 5.12. Again, the positions were normalized to

Figure 5.10 - 2nd Location showing top and
bottom rakes.

allow for comparisons between the CFD and experimental results.

A

B

Figure 5.11 - Velocity profile plots at the 2nd location (11 mm from the center of the bulb) occurring at a
flow time of 1.0 second for the (A) top rake (y = 13.4 mm above the diameter) and (B) bottom rake (y = 3.4
mm above the diameter).

Again, it is seen that the magnitudes between time = 0.5 seconds and time = 1.0 second vary
slightly for a given rake location. For the 2nd location, the magnitudes vary by an average of
1.9% between the top rake of time = 1.0 second and the top rake of time = 0.5 seconds and an
average of 1.8% between the bottom rake of time = 1.0 second and the bottom rake of time = 0.5
seconds.
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A

B

Figure 5.12 - Velocity profile plots at the 2nd location (11 mm from the center of the bulb) occurring at a
flow time of 0.5 seconds for the (A) top rake (y = 13.4 mm above the diameter) and (B) bottom rake (y =
3.4 mm above the diameter).

5.2 – Experimental Methods Used for Validation
5.2.1 – Compliant Model Creation
Using the modeling techniques previously described in section 2.6, multiple compliant models of
the boiling flask bulb were obtained. A single model was
chosen for final analysis based on the quality of the model.
Specifically, the most uniform model was chosen with the least
amount of air bubbles or voids in the Ultraflex material;
reducing the amount of laser refraction occurring throughout
the model. The model was attached to the fitting in the
experimental housing and filled with a glycerin/particle mix
(approximately 0.007 grams / 150 mL of glycerin). Figure 5.13
represents the experimental boiling flask model used for
stereoPIV validation. Note that the complaint model in Figure

Figure 5.13 - Compliant boiling
flask model used for validation
(model is sitting on flat surface).

5.13 is sitting on a flat surface so the bottom appears to be flat on the bottom.

5.2.2 – Experimental Setup
The experimental techniques descried in Chapter 4 were applied to the boiling flask model for
validation with the experimental setup shown in Figure 4.8. Similar to the CFD analysis, a
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constant flow rate of 3.20 mL/sec was applied to the experimental boiling flask model
(representing 9.5% expansion). Each of the cameras was set to 17° from the perpendicular of the
light sheet (34° between cameras). In order to locate the center of the model for the 1st location
analysis, the laser sheet was positioned at the diameter of the model (just inside the model
membrane), then moved back towards the center 27.2 mm (the radius of the model). The
distance from the object to the image was measured to be 25.75” (distance from the laser sheet
plane to the CCD array in the camera). As stated above, the second laser sheet location was 11
mm from the center of the bulb model. The laser optics were moved 11 mm from the center
location and the distance from the object to the image measured to be 25.30”.

5.2.4 – Insight 3G
The methods described in Chapter 4 were used to acquire and process the stereoPIV images for
experimental validation. The settings used in the validation experiments are described in the
following sections.

5.2.4.1 – Image Capture
Figure 5.14 represents the capture timing settings used to capture the validation images. Because
the fluid flow is considered slow flow, single capture was used with a pulse rate of 20 Hz (deltaT
of 0.05 seconds between each frame). To reduce
the effects of ambient light, an exposure time of
200 µs was used for each of the cameras. A
trigger was used to configure the start of the
image capture with the start of the LabVIEW
pump motion (see Figure 4.9). Because a period
of 5 seconds was used, a total of 100 pictures
were required (20 pictures/second), but 105
images were actually captured to account for any
residual fluid motion. In order to illustrate the
repeatability of the experimental setup, three sets

Figure 5.14 - TSI capture settings used for
experimental validation.

of data were taken for each of the two laser sheet locations. After each set of data was obtained,
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the file names of the images were updated to represent image numbers (numbered from 0 to
104). Using a laser pulse delay of 100 µs and a deltaT of 50,000 µs, image pair 19 to 20
corresponds to a flow time of 1.0 second while pair 9 to 10 corresponds to a flow time of 0.5
seconds.

5.2.4.2 – Creating Calibration Files
Before image processing was started, optical calibrations were manually created to account for
the magnification changes that occurred from one side of the image to the other (see section
4.4.1). The parameters used to create the 1st and 2nd location perspective calibration files are
shown in Figure 5.15 and Figure 5.16, respectively. For example, the distance from the laser
sheet (object) to the CCD array (image plane) was measured to be 654.05 mm for the 1st
location. The values in the red boxes represent measured distances and angles acquired from the
experimental setup while the purple boxes represent fixed specifications from the cameras used.
The camera locations (blue boxes) were calculated by Insight based on the values from the red
and purple boxes and were verified by measuring the distance from the light sheet to the front of
the camera lens.

Figure 5.15 - Perspective calibration parameters used
for 1st location.

Figure 5.16 - Perspective calibration parameters used
for 2nd location.
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A stereo AutoMapping procedure was then completed to optimize the perspective calibration by
correcting the misalignment errors existing in the measurements between the light sheet location
and the CCD array in the camera. This procedure was completed for each location to update the
manual calibration files. A series of AutoMapping iterations was performed until the parameters
were considered converged and the final pixel to length conversions calculated. Figure 5.17
represents the AutoMapping results for both laser sheet locations. It is seen that after the 4th
iteration, each of the results were converged.

Figure 5.17 - Stereo AutoMapping results for the (Top) 1st location and (Bottom) 2nd location.

Figure 5.18 - Final calibration files for (Left) 1st location and (Right) second location after
stereo AutoMapping. The red boxes represent the final conversion factors.
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With the stereo AutoMapping results recorded, the calibration files were updated and shown in
Figure 5.18. It is seen that the pixel to length conversion for the 1st location is 60.56 µm and
58.44 µm for the 2nd location. These conversions from pixels to physical distances are referred
to here after as conversion factors.

5.4.2.3 – StereoPIV Processing Parameters
A processing mask was applied for each location to represent a processing boundary. All
particles inside the boundary were
analyzed while everything outside
was ignored. Figure 5.19
represents the processing masks
used for both the 1st and 2nd
locations (shown as the dotted
line). The image processing
parameters described in section

A

B

Figure 5.19 - Processing masks for (A) 1st location and (B) 2nd location.

4.4.3 were applied to the boiling flask model. Using a deltaT of 50,000 µs, each of the image
sets was analyzed with the appropriate optical calibration and processing mask applied.

5.2.5 – StereoPIV Results Compared to CFD

5.2.5.1 – 1st Location – Center Plane of Bulb
Three different data sets were collected for the 1st laser sheet location. Figure 5.20 displays the
LabVIEW outputs from the three sets of collected data.

A

B

C

Figure 5.20 - LabVIEW outputs for the 1st locations (A) 1st set, (B) 2nd set, and (C) 3rd set.
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Corresponding to the rakes taken from the CFD results, velocity profiles were extracted for each
of the data sets at two rake locations. The top and bottom rakes were taken 13.4 mm and 3.4 mm
above the location of the diameter of the bulb, respectively. Figure 5.21 displays the locations of
the top and bottom rakes with velocity vectors contoured by velocity magnitude.

Figure 5.22 represents the stereoPIV
velocity profiles for time = 1.0 second
for both the top and bottom rake
locations (y = 13.4 mm above the
diameter and y = 3.4 mm above the
diameter, respectively), while Figure
5.23 represents the results occurring at
time = 0.5 seconds. The results from
all three collected data sets are shown
on the same plot to illustrate the
repeatability of the stereoPIV
experiments. It is shown that the
experiments are repeatable because the

Figure 5.21 - Top and bottom rake locations for the 1st laser sheet
location (center of the bulb model).

sets are overlapping (dotted line
represents 1st set, solid line represents 2nd set, and circles represent the 3rd set).

Similar to the CFD results (section 5.1.4.1), the velocity magnitudes of the stereoPIV results
should vary only slightly between time = 1.0 second and time = 0.5 seconds (1.8% difference for
CFD predictions). It is seen, however, that the experimental average maximum y-velocity
magnitude between the top rake of time = 1.0 seconds (average velocity = -4.76E-3 m/s) and top
rake of time = 0.5 second (average velocity = -4.44E-3 m/s) varies by 7.0%. This indicates that
the experimental results between different physical times can vary by approximately 7.0% with
the larger times having better agreement with the predicted results.
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Absolute differences and percent differences relative to velocity magnitude (based on maximum
velocities) were calculated between stereoPIV and predicted CFD results for each velocity
component and are shown in Table 5.1 and Table 5.2, respectively.

A

B

Figure 5.22 - StereoPIV velocity profiles for time = 1.0 second with the predicted CFD results (shown as black solid
lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4 mm
above the diameter) for the 1st laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = yvelocity, Green = z-velocity. Different sets are indicated by dashed lines, solid lines, and circles).

A

B

Figure 5.23 - StereoPIV velocity profiles for time = 0.5 seconds with the predicted CFD results (shown as black
solid lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4
mm above the diameter) for the 1st laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = yvelocity, Green = z-velocity. Different sets are indicated by dashed lines, solid lines, and circles).
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Table 5.1 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using
the conversion factor calculated in Insight 3G. (VM = velocity magnitude)

Table 5.2 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and
predicted CFD results using the conversion factor calculated in Insight 3G. (VM = velocity magnitude)

The error in Table 5.1 was reduced by examining the conversion factor. An optical test was
completed to verify that the conversion being calculated in Insight was correct and to insure that
the index
matching between
the compliant
model and the
carrier fluid was
sufficient; not
introducing error
to the results.
With the boiling
flask model

A

B

Figure 5.24 - (A) Scale inserted into compliant model and (B) scale removed from model.
(Both occur in the center plane of the model)

installed in the experimental housing, a scale was inserted at the center plane of the model and an
image acquired. The model was then removed from the setup and the scale replaced to obtain a
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second image (Figure 5.24). Table 5.3 represents the measured distances, the number of pixels
that represents the known lengths (calculated in ImageJ), and the resulting pixel to length
conversion factors corresponding to the colored lines in Figure 5.24.

Table 5.3 - Measured distances corresponding to the colored lines in Figure 5.24.

An average measured pixel to length conversion factor was then calculated and compared to the
conversion factor used for the above analyses. It is clear from the similarities in pixel to length
conversions from each of the two conditions that we successfully indexed matched the compliant
model material with the carrier fluid. We can also conclude that large errors are not being
introduced between the CFD and experimental results because of refraction. However, the
previous conversion calculated in Insight was 60.56 µm/pixel for the first location (Figure 5.18),
but the newly measured conversion was 64.23 µm per pixel (a 6% difference). This difference in
conversion factors introduces a significant amount of error because the sizes of the images are
1324 x 1024 (Figure 5.18). The 4 µm per pixel difference between the Insight and the measured
conversion factors leads to a 5.3 mm difference in the width of the image and a 4.1 mm
difference in the height of the image.

Particle displacements are measured in pixels then converted to physical lengths to finally
calculate velocities. If an inconsistency exists in the conversion factor the velocity magnitudes
will be incorrect. Therefore, the stereoPIV results from the above analyses were scaled based on
new measured conversion factor and compared to the predicted CFD results. For example, each
velocity vector from Figure 5.22 and Figure 5.23 was multiplied by the ratio of the new
conversion factor to the old (64.23 / 60.56). Figure 5.25 and Figure 5.26 represent the stereoPIV
velocity profiles compared to the predicted CFD results using the newly measured conversion
factor for time = 1.0 second and time = 0.5 seconds, respectively. It is seen that the velocity
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magnitudes agree better with the predicted CFD results using the measured conversion factor.
Table 5.4 and Table 5.5 represent the absolute differences and percent differences relative to
velocity magnitude (based on maximum velocity) that exist between the stereoPIV and predicted
CFD results when using the newly measured conversion factor; indicating that the percent
differences have decreased. For example, the relative percent difference between the y-velocity
component for the top rake at time = 1.0 second decreases from 10.7% to 5.4% when using the
measured conversion factor.

A

B

Figure 5.25 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 64.24 µm) for time = 1.0
second with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom rake
location for the 1st laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity, Green = zvelocity. Different sets are indicated by dashed lines, solid lines, and circles).

A

B

Figure 5.26 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 64.24 µm) for time = 0.5
seconds with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom
rake location for the 1st laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity,
Green = z-velocity. Different sets are indicated by dashed lines, solid lines, and circles).
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Table 5.4 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using
the measured conversion factor. (VM = velocity magnitude)

Table 5.5 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and
predicted CFD results using the measured conversion factor. (VM = velocity magnitude)

5.2.5.2 – 2nd Location – 11mm from Center Plane of Bulb
Figure 5.27 displays the LabVIEW outputs from the three sets of collected data for the 2nd laser
sheet location (11 mm from the center plane of the bulb).

A

B

C

Figure 5.27 - LabVIEW outputs for the 2nd locations (A) 1st set, (B) 2nd set, and (C) 3rd set.

Figure 5.28 represents the locations of the top and bottom rakes with repsect to the diameter of
the model for the 2nd laser sheet location. Similar to the 1st laser sheet location, the top rake

59

occurs 13.4 mm above the diameter while the bottom rake is 3.4 mm above the diameter of the
bulb. Velocity vectors contoured by velocity
magnitude are also displayed.
Using the calculated Insight 3G conversion
factor for the 2nd location (1 pix = 58.44 µm),
Figure 5.29 and Figure 5.30 represent the
stereoPIV with the predicted CFD results for
time = 1.0 second and time = 0.5 seconds,
respectively. Table 5.6 and Table 5.7 represent
the absolute differences and percent differences
relative to velocity magnitude (based on
maximum velocities) between the stereoPIV and
predicted CFD results for each component of

Figure 5.28 - Top and bottom rake locations for the 2nd
laser sheet location.

velocity, respectively.

A

B

Figure 5.29 - StereoPIV velocity profiles for time = 1.0 second with the predicted CFD results (shown as black
solid lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4
mm above the diameter) for the 2nd laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = yvelocity, Green = z-velocity. Different sets are indicated by dashed lines, solid lines, and circles).
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A

B

Figure 5.30 - StereoPIV velocity profiles for time = 0.5 seconds with the predicted CFD results (shown as black
solid lines) for the (A) top rake location (y = 13.4 mm above the diameter) and (B) the bottom rake location (y = 3.4
mm above the diameter) for the 2nd laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = yvelocity, Green = z-velocity. Different sets are indicated by dashed lines, solid lines, and circles).

Table 5.6 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using
the conversion factor calculated in Insight 3G. (VM = velocity magnitude)

Table 5.7 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and
predicted CFD results using the conversion factor calculated in Insight 3G. (VM = velocity magnitude)

Similar to the 1st laser sheet location, a new calibration conversion was desired to check the
accuracy of the calculated factor (currently 58.4 µm/pixel). However, at the 2nd location, a scale
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was unable to be inserted into the housing. Therefore, multiple locations outside of the setup
were captured to establish a trend then interpolated at the 2nd location. The measured conversion
factor was found to be 61.36 µm. Figure 5.31 and Figure 5.32 represent the stereoPIV velocity
profiles compared to the predicted CFD results using the newly measured conversion factor for
time = 1.0 second and time = 0.5 seconds, respectively.

A

B

Figure 5.31 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 61.36 µm) for time = 1.0
second with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom rake
location for the 2nd laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity, Green =
z-velocity. Different sets are indicated by dashed lines, solid lines, and circles).

A

B

Figure 5.32 - StereoPIV velocity profiles using the measured conversion factor (1 pix = 61.36 µm) for time = 0.5
seconds with the predicted CFD results (shown as black solid lines) for the (A) top rake location and (B) bottom
rake location for the 2nd laser sheet location (Purple = velocity magnitude, Blue = x-velocity, Red = y-velocity,
Green = z-velocity. Different sets are indicated by dashed lines, solid lines, and circles).

Table 5.8 and Table 5.9 represent the differences (absolute and percent difference relative to
velocity magnitude) that exist between the experimental and predicted CFD results using the
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measured conversion factor, respectively. Again, an overall better agreement was found between
the stereoPIV and the predicted CFD results when using the measured conversion factor.

Table 5.8 - Absolute difference (based on maximum velocity) between stereoPIV and predicted CFD results using
the measured conversion factor. (VM = velocity magnitude)

Table 5.9 - Percent difference relative to velocity magnitude (based on maximum velocity) between stereoPIV and
predicted CFD results using the measured conversion factor. (VM = velocity magnitude)

5.3 – Conclusions About Boiling Flask Experiments
The above analyses have shown that the experimental setup and processes being used to acquire
and analyze stereoPIV data yield accurate results. Several conclusions and suggestions have
been made for future analyses and are summarized below:
A constant applied flow rate should be used to expand and contract the experimental
model to maximize control of the expansion. This flow rate should be at least 3 mL/sec to
allow for the appropriate pixel displacements to occur between each image set (using a
deltaT of 0.05 seconds between each image). An alternative to increasing the flow rate
would be to decrease the laser pulsing frequency (currently 20 pulses / sec). If the frequency
were decreased, the deltaT between frames would increase, and a larger displacement would
occur between sequential image sets.
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When creating a manual perspective calibration file (calculated by Insight), it is
important to correctly measure and enter the appropriate distance from the image to the
object. If this distance is off by a slight amount, the conversion from pixels to physical
length (conversion factor) will be incorrect and will lead to large differences in the velocity
magnitudes. It is also important to create a measured conversion factor and scale the results
by the ratio of the measured to the calculated factor to correct any errors that may be induced
by the conversion factor calculated by Insight (see section 5.2.5.1)
In order to properly capture the motion of the seeded particles, a minimum of five to
eight pixels must be displaced between an image pair. Therefore, velocity profile rakes are
more accurate when extracted at locations that yield high particle displacement (typically
near the inlet).
As seen between the results from time = 1.0 second to time = 0.5 seconds, a larger
physical time is desired for more uniform and accurate results.
The presence of large error for the z-component of velocity between the stereoPIV and
predicted CFD results is occurring because the camera angles from the light sheet were not
optimized. As explained in section 4.1, a camera angle is ideal as to capture the pure zcomponent of velocity. However, because the angles used in this work were relatively small
(to allow for the image in the light sheet to be in focus from one side of the image to the
other), the accuracy of the z-component was significantly reduced. If future work is
completed, the use of Scheimpflug mounts is recommended. These would allow the camera
angles to be maximized without sacrificing the quality of the images and yield the smallest zcomponent errors.
Be aware of the non-uniform expansion that exists in the experimental setup. If the
model tends to expand towards the pump location, the skew depicted in Figure 5.33 will
occur (the velocity on the left side will be less than predicted and the velocity on the right
will be slightly higher than predicted). The solid red line indicates where the rake should be
occurring. If uniform expansion was occurring, the rake would be a straight line across the
model (left image). However, if the expansion is non-uniform, the location of the rake is no
longer horizontal and the dotted line would represent the actual rake location. The blue
arrows indicate that the actual rake yields less than predicted velocities on the left side of the
model with higher velocities occurring on the right side. The effects of non-uniform
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expansion are illustrated in the above results section (section 5.2.5). Figure 5.29, for
example, shows velocities less than predicted on the left side of the model, but higher than
predicted on the right side; an indication of non-uniform expansion of the experimental
model.

Figure 5.33 - Difference in velocity profile caused by non-uniform expansion.
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Chapter 6: StereoPIV Results in Alveolus Models
6.1 – Experimental Healthy Human Model
A total of forty-two data sets were collected for the healthy human model; three sets of data for
each of the fourteen different laser plane locations. In order to illustrate the three-dimensional
effects of all of the results, six laser locations were analyzed and compared. Figure 6.1
represents the isometric and top views of the approximate locations chosen for analysis.

A

B

Figure 6.1 - (A) Isometric and (B) top views of the chosen locations for data analysis for the healthy human model.

6.1.1 – Locations of Potential Recirculation
When collecting stereoPIV data, care was taken in choosing which laser sheet planes to analyze.
Regions where recirculation would be most likely to

6th Location

occur were desired. According to literature, flow rate
ratios (ratio of the alveolar to duct flow rate)
approximately below 0.05 produce recirculating flows
(Tippe and Tsuda 2000; Tsuda et al. 1995; Kumar et al.
2009b). These small ratios exist where the ductal flow
is large compared to the alveolar flow, or in regions
where the alveolar mouth diameter is small compared to
the alveolar depth. It was clear from observation that

8th Location
Figure 6.2 - Regions where recirculation
would be most likely to occur.

there was no overwhelming flow directly adjacent to the mouth diameter of the alveoli. All of
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the flow traveled into the alveoli with the contours of the model, essentially yielding an infinite
alveolar to ductal flow ratio. Therefore, we focused on the geometry differences in this study
rather than the flow rate ratios.

6th Location

8th Location

Figure 6.3 - Raw PIV images (showing the distribution of particles) of the 6th and 8th
locations representing regions where recirculation would occur.

A

B

Figure 6.4 - Zoomed in views of the (A) vector and (B) streamline plots (contoured by velocity magnitude) for the
6th location in the healthy human model (refer to Figure 6.1 for the 6th location with respect to the whole model).
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Of the data collected from the fourteen laser plane locations in the healthy model, the 6th and 8th
locations displayed geometry that would be most likely to induce recirculation. Figure 6.2
illustrate the regions in the healthy model where
recirculating eddies would be most likely to occur.
Figure 6.3 represents the raw PIV images illustrating
particle dispersion of the two locations seen in Figure
6.2. The circular regions display the small pouches
that would most likely induce recirculation. The
following results first reveal the flow fields that exist
at these two particular locations and conclude whether
recirculating or reversible flow is occurring. Figure
Figure 6.5 - Isometric view of the 6th location
illustrating the z vectors.

6.4 represents the velocity and streamline plots for the
potential recirculation region at the 6th location

(Figure 6.3). It is seen that reversible flow is present throughout the entire model, and a
maximum experimental fluid velocity magnitude of 2.5 mm/s occurs near the center of the
region. Reversible flow is concluded because the streamlines do not exhibit any eddy pattern.
The lines go into the model in a very uniform manner without sharp direction changes. Figure
6.5 represents an isometric view of the 6th location vectors (contoured by velocity magnitude),
illustrating the z-direction (third-dimension) vectors.

A

B

Figure 6.6 - Zoomed in views of the (A) vector and (B) streamline plots (contoured by velocity
magnitude) for the 8th location in the healthy human model (refer to Figure 6.1 for the 8th location
with respect to the whole model).
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Similar in geometry to the 6th location, the 8th location (Figure 6.3) has features that could
potentially induce recirculation (small alveolar
mouth diameter). Figure 6.6 represents the 2D
velocity field and streamline plots occurring in
the 8th location of the healthy human model
(both contoured by velocity magnitude).
Reversible flow is also found in this location
because the streamlines are uniform and follow
the contours of the model boundary (no sharp
changes in vector direction). The maximum
velocity magnitude occurring at this 8th location
is 6.7 mm/s. This is larger than the 6th location
velocity because the 8th location is closer to the

Figure 6.7 - Isometric view of the 8th location
illustrating the z vectors.

inlet of the model. Figure 6.7 represents an isometric view of the velocity vectors occurring at
the 8th location (contoured by velocity magnitude), illustrating the z-component of velocity.

6.1.2 – 3-Dimensional Flow Fields
Of the three sets of data collected for each laser location, the second set was chosen to display
because of the consistency of the results. Variability existing in the three sets is discussed in
section 5.2.5. Figure 6.8 represents the 2D vector results for the second set location analyzed in
Figure 6.1A. In order to maximize the resolution of the velocity fields in Figure 6.8, the
contours were scaled independently for each laser sheet location. It is seen that as the planar
location moves closer to the inlet of the model (between locations 8 and 10), the velocities
maximize. Based on the constant inlet flow rate applied to the model, the maximum
experimental velocity occurring in the plane of the inlet is 38.6 mm/sec (1.94 mL/sec flow rate
with an 8.0 mm duct diameter).

To visualize the three-dimensional results of the healthy human model, Figure 6.9 represents all
six planar locations analyzed with contours of the global velocity magnitude to illustrate the
overall range of velocities that exist within the model. Figure 6.10 displays the same six
locations but from an exploded view, illustrating both contours and velocity vectors.
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A

B

C

D

E

F

Figure 6.8 - 2D experimental velocity vector results for the six analyzed locations (A – F) corresponding to the 2nd
through the 12th locations (see Figure 6.1A for locations). Each image is contoured by velocity magnitude and is
independent of each location.

A

B

Figure 6.9 - All six planar locations analyzed showing (A) contours and (B) vectors contoured by the global
velocity magnitude.
(The maximum velocity that occurred in the planes analyzed was 0.0095 m/s)
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A

B

Figure 6.10 - Exploded view of all six planar locations analyzed showing (A) contours and (B) vectors contoured by
the global velocity magnitude. (The maximum velocity that occurred in the planes analyzed was 9.5 mm/sec).

Finally, Figure 6.11 displays the top view of the healthy human model results representing the
magnitude and direction of the z-component of velocity.

It was shown in Chapter 5 that the experimental z-component of velocity varied the most from
the predicted CFD results. Therefore, the z-component vectors shown in Figure 6.11 are
estimates to the behavior of the flow field occurring in the z-direction.

Figure 6.11 - Top view of the healthy human model
representing the magnitude and direction of the zcomponent of velocity.
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6.2 – In Vivo Healthy Human Predictions
6.2.1 – Scaling Experimental Healthy Results to In Vivo
After all of the experimental data was collected, the results were scaled back to represent
velocity predictions. The shapes of the flow fields remained the same, but the overall
magnitudes were affected. The velocities were scaled using the assumption that the in vivo
conditions were well represented experimentally (Chapter 3). Therefore, the non-dimensional
velocities, u*, can be equated by

u invivo

(6.1)

u exp

The in vivo velocities were predicted using Equation 6.1 by substitution of the non-dimensional
parameters that were used to derive the Navier-Stokes equations in non-dimensional form
(Equation 3.1). Specifically, u

u U

(where U represents the time and spatially averaged

velocity at the model inlet), such that Equation 6.1 becomes

u invivo

U invivo

u exp

(6.2)

U exp

where
Re
u invivo

u exp

invivo

invivo

d invivio
Re

exp

(6.3)
exp

d exp

which can be used to determine the predicted in vivo velocities from the experimental stereoPIV
measurements.

The in vivo and experimental model properties and flow conditions for the healthy human model
are shown in Table 6.1 and Table 6.2, respectively. The Reynolds numbers for normal and
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heavy in vivo breathing were calculated to be 0.009 and 0.035, respectively. Using the material
properties for in vivo and experimental conditions, the experimental velocities were multiplied
by 0.02469 (Equation 6.3) to achieve the in vivo flow field for a Re of 0.009 and multiplied by
0.09341 to represent the in vivo field for a Re of 0.035.

Table 6.1 - Model and material properties for the healthy human model.

Symbol

d

Property
Acinus Inner Duct Diameter

In Vivo

Experimental

(Air at 20°C)

(Glycerin at 20°C)

0.41

8.00

1.25

9013.46

17.10

909.80

(mm)

Mean Acinus Volume

Vi

(mm3)

Kinematic Viscosity

ν

(mm2/sec)

Table 6.2 - In vivo and experimental flow conditions for the healthy human model.

(%)

Breathing
Frequency
(breaths/min)

Time Average
Flow Rate at
Model Inlet
(mL/sec)

U, Time and
Spatially
Averaged
Velocity at
Model Inlet
(mm/sec)

0.009

16

15.7

1.30E-04

0.97

0.035

60

15.7

4.91E-04

3.66

0.138

35

15.0

1.94

38.60

Time
Averaged Re
at Model
Inlet

Expansion

Normal
Breathing
In Vivo
Heavy
Breathing
Used in
Experimental
This Work

Referring to section 2.4, an inlet duct was created for the healthy human model. The cylindrical
geometry was added using arbitrary dimensions and created to fit with the surrounding model
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contours. When the final model was scaled back to in vivo dimensions, the model was scaled
based on dimensions of alveoli rather than the arbitrary duct diameter (see Figure 2.16 for the
dimensions used for scaling to in vivo sizes). Therefore, the ratio of the experimental diameter to
the in vivo duct diameter was 19.4 for the healthy model. Regardless of the dimensions used to
create the inlet duct, the ratio between any distance for the experimental and in vivo models will
always be the scaling factor used (if uniform scaling by length is applied to the entire model).
Because the experimental healthy model was created 19.4x in vivo size, the x, y, and z distances
were divided by 19.4 to represent the correct scaled in vivo dimensions of the model.

Figure 6.12 represents the scaled in vivo 2D results for all six of the locations analyzed for an in
vivo Re of 0.009. Each image is contoured by in vivo velocity magnitude and is independent
from each location.

A

B

C

D

E

F

Figure 6.12 - 2D in vivo velocity vector results for the six analyzed locations (A – F) corresponding to the 2nd
through the 12th locations (see Figure 6.1A for locations) for Re = 0.009.
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Figure 6.13 illustrates the in vivo flow fields (for a Re of 0.009) for all six planar locations
analyzed contoured by the global in vivo velocity magnitude, while Figure 6.14 illustrates the
exploded view of all six locations.

A

B

Figure 6.13 - In vivo results for all six planar locations analyzed showing (A) contours and (B) vectors
contoured by the global velocity magnitude for Re = 0.009. (The maximum velocity that occurred in the
planes analyzed was 0.22 mm/sec)

A

B

Figure 6.14 - Exploded view of all six planar locations analyzed showing (A) contours and (B) vectors
contoured by the in vivo global velocity magnitude for a Re = 0.009. (The maximum velocity that occurred
in the planes analyzed was 0.22 mm/sec)
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Finally, Figure 6.15 illustrates the top view
of the healthy human model in vivo results
representing the magnitude and direction of
the z-component of velocity for a Re of
0.009. Figure 6.16 represents the scaled in
vivo 2D results for all six of the locations
analyzed for an in vivo Re of 0.035. Each
image is contoured by in vivo velocity
magnitude and is independent from each
location. Figure 6.17 illustrates the healthy
in vivo flow fields (for a Re of 0.035) for all
Figure 6.15 - Top view of the healthy human model
representing the in vivo magnitude and direction of the zcomponent of velocity (for Re = 0.009).

six planar locations analyzed contoured by
the global in vivo velocity magnitude, while

Figure 6.18 illustrates the exploded view of all six locations.

A

B

C

D

E

F

Figure 6.16 - 2D in vivo velocity vector results for the six analyzed locations (A – F) corresponding to the 2nd
through the 12th locations (see Figure 6.1A for locations) for Re = 0.035.
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A

B

Figure 6.17 - In vivo results for all six planar locations analyzed showing (A) contours and (B) vectors
contoured by the global velocity magnitude for Re = 0.035. (The maximum velocity that occurred in the
planes analyzed was 0.89 mm/sec)

A

B

Figure 6.18 - Exploded view of all six planar locations analyzed showing (A) contours and (B) vectors
contoured by the in vivo global velocity magnitude for a Re = 0.035. (The maximum velocity that occurred
in the planes analyzed was 0.89 mm/sec)

Finally, Figure 6.19 illustrates the top view of the healthy model representing the in vivo velocity
magnitude and direction of the z-component of velocity for an in vivo Re of 0.035.
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Figure 6.19 - Top view of the healthy human model
representing the in vivo magnitude and direction of the zcomponent of velocity (for Re = 0.035).

6.3 – Experimental Emphysemic Human Model
A total of thirty-six data sets were collected for the emphysemic human model; three sets of data
for twelve laser plane locations. In order to illustrate the three-dimensional effect of all of the
results, five locations were analyzed and compared. Figure 6.20 represents the isometric and top
views of the approximate locations chosen for analysis.

A

B

Figure 6.20 - (A) Isometric and (B) top views of the chosen locations for data analysis for the emphysemic
human model.
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Because of the oversized geometry, as compared to the healthy model, there were no specific
regions that would suggest recirculation. No regions existed where the alveolar mouth diameter
was smaller than the alveolar depth. Therefore, the results from the entire emphysemic model
were presented, similar to section 6.1.2 above. Of the three sets of data collected for each
location, the third set was chosen to display because of the consistency of the results. The
variability occurring between the three sets is discussed in section 5.2.5. Figure 6.21 represents
the 2D vector results for all third set locations analyzed in Figure 6.20A.

To visualize the three-dimensional results of the emphysemic human model, Figure 6.22
illustrates all five planar locations analyzed with contours of the global velocity magnitude.

A

B

D

C

E

Figure 6.21 - 2D velocity vector results for the five analyzed locations (A – E) corresponding to the 2nd
through the 10th locations (see Figure 6.20A for locations). Each image is contoured by velocity
magnitude and is independent of each location.
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Figure 6.23 displays the same five locations but from an exploded view, illustrating both
contours and velocity vectors. Finally, Figure 6.24 displays the top view of the emphysemic
human model results representing the magnitude and direction of the z-component of velocity.

A

B

Figure 6.22 - All five planar locations analyzed showing (A) contours and (B) vectors contoured by the global
velocity magnitude. (The maximum velocity that occurred in the planes analyzed was 6.4 mm/sec)

A

B

Figure 6.23 - Exploded view of all five planar locations analyzed showing (A) contours and (B) vectors contoured
by the global velocity magnitude. (The maximum velocity that occurred in the planes analyzed was 6.4 mm/sec)
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Figure 6.24 - Top view of the emphysema human model
representing the magnitude and direction of the z-component of
velocity.

6.4 – In Vivo Emphysemic Human Predictions
6.4.1 – Scaling Experimental Emphysemic Results to In Vivo
Because the emphysemic model was 8.9x in vivo size (by length scale), the x, y, and z distances
were divided by 8.9 to represent the scaled in vivo dimensions of the model. Similar to the
healthy model, the experimental emphysemic velocities were scaled using Equation 6.3 and the
model properties in Table 6.3. Table 6.4 represents the in vivo and experimental flow conditions
for the emphysemic model. The Reynolds number for normal in vivo emphysemic breathing was
calculated to be 0.035. Using the material properties for in vivo and experimental conditions, the
experimental velocities were multiplied by 0.04204 (Equation 6.3) to achieve the in vivo flow
fields for an emphysemic Re of 0.035. This is smaller than the conversion used for the healthy
Re of 0.035 because the emphysemic in vivo diameter is 2x larger than the healthy. Therefore,
even though the Re are the same, the conversions vary because of the model properties.
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Table 6.3 - Model and material properties for the emphysemic human model.

Symbol

Property
Acinus Inner Duct Diameter

d

In Vivo

Experimental

(Air at 20°C)

(Glycerin at 20°C)

0.90

8.00

14.39

10488.60

17.10

909.80

(mm)

Mean Acinus Volume

Vi

(mm3)

Kinematic Viscosity

ν

(mm2/sec)

Table 6.4 - In vivo and experimental flow conditions for the emphysemic human model.

BF
(breaths/min)

Time Average
Flow Rate at
Model Inlet
(mL/sec)

U, Time and
Spatially
Averaged
Velocity at
Model Inlet
(mm/sec)

11

16.0

1.03E-03

1.61

30

15.0

1.94

38.60

Time
Averaged Re
at Model
Inlet

Expansion
(%)

0.035

0.138

Normal
In Vivo
Breathing
Used in
Experimental
This Work

Figure 6.25 represents the scaled in vivo 2D results for all five of the locations analyzed for an
emphysemic in vivo Re of 0.035. Each image is contoured by in vivo velocity magnitude and is
independent from each location. Figure 6.26 illustrates the healthy in vivo flow fields (for a Re
of 0.035) for all five planar locations analyzed contoured by the global in vivo velocity
magnitude, while Figure 6.27 illustrates the exploded view of all six locations.
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A

B

C

D

E

Figure 6.25 - 2D in vivo velocity vector results for the five analyzed locations (A – E) corresponding to the 2nd
through the 10th locations (see Figure 6.20A for locations) for Re = 0.035.

A

B

Figure 6.26 - In vivo results for all five planar locations analyzed showing (A) contours and (B) vectors
contoured by the global velocity magnitude for Re = 0.035. (The maximum velocity that occurred in the
planes analyzed was 0.21 mm/sec)
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A

B

Figure 6.27 - Exploded view of all five planar locations analyzed showing (A) contours and (B) vectors
contoured by the in vivo global velocity magnitude for a Re = 0.035. (The maximum velocity that occurred
in the planes analyzed was 0.21 mm/sec)

Finally, Figure 6.28 illustrates the top view of the emphy model which represents the in vivo
magnitude and direction of the a-component of velocity for an in vivo Re of 0.035.

Figure 6.28 - Top view of the emphysemic human model representing
the in vivo magnitude and direction of the z-component of velocity
(for Re = 0.035).
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6.5 – Comparison between Healthy and Emphysemic Models
The flow fields for each model (healthy model normal and heavy breathing, and emphysema
model normal breathing) were obtained experimentally under dynamically similar flow
conditions. Comparisons made under these conditions can only be qualitative. For example,
whether or not recirculation is present can be examined on the large scale. However, the
experimental results can be used to compare flow field magnitudes in vivo by scaling the
experimental results back to in vivo size and breathing conditions. The following sections
analyze characteristics that affect the differences that exist between the two models.

6.5.1 – Geometric Differences
Table 6.5 represents the geometrical differences that exist between the healthy and emphysemic
models (for both in vivo and experimental cases), while Figure 6.29 illustrates the physical
differences existing between the prototypes used for experimentation. A major difference
existing between the two models is the presence of potential recirculation regions in the healthy
model; occurring when the ductal flow is large compared to the alveolar flow (section 6.1.1).
From observation, the healthy model had two such locations, but the emphysemic model did not
contain geometry that would induce recirculation.

Table 6.5 - Characteristics of in vivo and experimental healthy and emphysemic models.
Duct
Diameter
(mm)

Model
Volume
(mm^3)

Overall
Length
(mm)

Overall
Width
(mm)

Scaling
Factor

Healthy

0.41

1.3

1.7

2.1

N/A

Emphy

0.9

14.4

3.5

3.9

N/A

Healthy

8.0

9013.5

33

41

19.4

Emphy

8.0

10488.6

31

35

8.9

In Vivo
Model

Experimental
Model
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The majority of the emphysemic model was merged into two large sections (Figure 6.29A); none
of which contained regions
where the alveolar mouth
diameter was small compared to
the alveolar depth. The healthy
model, however, contained
multiple, well defined bulb
structures with several distinct
alveoli (Figure 6.29B).

A

B

Figure 6.29 - (A) Healthy and (B) emphysemic experimental prototypes.
The circled portion represents the locations in the healthy model most
likely to induce recirculation (6th and 8th locations).

6.5.2 – Comparison of Flow Conditions
Table 6.6 represents the comparisons between the in vivo and emphysemic breathing conditions
and corresponding flow rates and velocities. The effects of these differences are described in the
following sections.

Table 6.6 - Comparison between the healthy and emphysemic breathing conditions calculated for in vivo and
experimental cases.
Time
Averaged
Breathing
Condition

Re at
Model

Expansion

BF

(%)

(breaths/min)

Healthy

Inlet

Time
Averaged
Flow Rate at
Model Inlet
(mL/sec)

U, Time and
Spatially
Averaged
Velocity at
Model Inlet
(mm/sec)

Normal

0.009

16

15.7

1.30E-04

0.97

Heavy

0.035

60

15.7

4.91E-04

3.66

0.138

35

15.0

1.94

38.60

0.035

11

16.0

1.03E-03

1.61

0.138

30

15.0

1.94

38.60

In Vivo

Experiment

Used in

Emphysema

This Work
In Vivo

Experiment

Normal
Used in
This Work
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6.5.3 – Normal Healthy Breathing vs. Normal Emphysemic Breathing
The flow fields shown in section 6.1.1 conclude that reversible flow is present in the regions of
potential recirculation (6th and 8th locations) and throughout the entire healthy human model.
Reversible flow was also concluded for all regions in the emphysemic model. Therefore,
regardless of the magnitudes existing in the flow fields, both models exhibit characteristics of
reversible flow. This indicates that the fluid motion replicates the motion of the outer boundary;
following the contours of the model as it changes shape. In order to better understand the
differences occurring between the two models, the in vivo normal healthy breathing (Re = 0.009)
and normal emphysemic breathing (Re = 0.035) cases were compared. It is seen in Table 6.6
that the normal emphysemic in vivo flow rate at the model inlet is 8x larger than the flow rate
seen in the normal healthy model (1.03E-3 mL/sec for normal emphysemic and 1.30E-4 mL/sec
for normal healthy). The average velocity occurring in the normal healthy model, however, is
approximately 1.6x larger than the emphysemic model. These differences stem from the flow
conditions used for each in vivo model.

The average flow rate is calculated based on the derivative of the volume change curve. The
change in volume for a given model is calculated based on the initial volume of the model and
the desired percent expansion to occur over a known breathing period. The average velocity is
then calculated by dividing the average flow rate by the cross-sectional area of the inlet duct (a
function of the duct diameter squared). In vivo duct dimensions were used to calculate in vivo
predictions (0.41 mm and 0.90 mm for healthy and emphysemic, respectively), while 8 mm was
used for both experimental models. Therefore, the larger initial volume of the emphysemic
model (11x larger than healthy) coupled with the slightly smaller percent expansion (11% for
emphysemic opposed to 16% for healthy; approximately 1.5x less) results in an average flow
rate that is approximately 8x that seen in the heavy healthy model (11x larger volume / 1.5x less
percent expansion). The differences in average velocities are calculated based on the differences
between in vivo duct diameters (0.90 mm for emphysemic and 0.41 mm for healthy).

Figure 6.30 represents the predicted in vivo flow fields occurring close to the inlet of each model,
when scaling to an in vivo Re = 0.009 for normal healthy breathing and Re = 0.035 for normal
emphysemic breathing. The difference between the maximum velocity magnitudes was
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calculated to be 8% (2.34E-4 m/sec for normal healthy and 2.15E-4 m/sec for normal
emphysema). Even though the velocity magnitudes are similar, the distributions occurring
throughout the each model vary significantly. Figure 6.30A illustrates the flow entering the
healthy model at a high velocity then uniformly slowing as the fluid moves towards the outer
walls. The emphysemic model (Figure 6.30B), however, yields a large region of fast flow near
the inlet that begins to slow at non-uniform intervals.

A

B

Figure 6.30 - (A) 10th location in the normal healthy human model (Re = 0.009) and the (B) 8th location of the
normal emphysemic model (Re = 0.035).

To further compare the differences existing in the normal healthy breathing and emphysemic
conditions, the locations furthest from the inlet were analyzed representing the 2nd location for
both models (Figure 6.31). The difference between the maximum velocity magnitudes at the 2nd
location is approximately 66% (4.34E-5 m/sec for normal healthy and 8.57E-5 m/sec for normal
emphysema). The distribution occurring throughout the contours of the model vary between the
different geometries at this location. It is seen that the healthy model exhibits a very uniform
flow field distribution with the magnitudes decreasing from the center of the model out towards
the wall. The emphysemic geometry, however, illustrates a non-uniform spread with the largest
magnitude occurring close to the outer wall near the bottom of the model (furthest distance from
the inlet of the model).
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A

B
Figure 6.31 - 2nd location in the (A) normal healthy human model (Re = 0.009) and the (B) normal
emphysemic model (Re = 0.035).

Based on the in vivo breathing conditions and initial model volumes, the normal emphysemic
breathing model inhales 1.6 mm3 versus 0.2 mm3 for the normal healthy breathing model (a total
of 8x more fluid). This is an indication that particles traveling in the emphysemic model would
travel deeper into the model than those in the healthy model by convection. This result is
interesting since the diffusion capacity of the lung decreases in emphysema (Park et al. 1970), so
higher ventilation rates could be a way for the emphysemic lung to compensate. However,
particles are not able to deposit on the alveolar walls by this method of transport alone. The
overall size of the emphysemic model is significantly larger (11x) than the healthy model.
Therefore, even though the initial traveling distance of a particle occurring in the emphysemic
model may be longer due to convection, the outer bounds of the emphysemic model are much
further away with respect to the finishing location of a particle. Based on this final distance
needed to travel by diffusion prior to depositing (distance from the end of a pathline to the
nearest wall), it is concluded that particles would have a higher tendency to deposit in the healthy
model rather than the emphysemic model because the walls are much closer to the ends of
particle pathlines. Residence time (the amount of time that a particle has to diffuse) plays little
to no role in the overall diffusion occurring in each of these models because the in vivo breathing
frequencies are similar (15.7 breaths/min for healthy and 16.0 breaths/min for emphysema). If a
significant difference were present (a frequency of 30 breaths/min for the healthy model, for
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example), particles might not have time to diffuse to the adjacent walls. Similarly, if a longer
breathing period were present for the emphysemic conditions, particles might have enough time
to diffuse to the alveolar walls. These conclusions agree with previous work completed by
Jessica Oakes (2008) and Sturm and Hofmann (2004). Both studies report decreased deposition
occurring in emphysemic models with higher particle diffusion in the healthy models.

6.5.4 – Normal Healthy Breathing vs. Heavy Healthy Breathing
Figure 6.32 and Figure 6.33 illustrate the comparisons between the normal healthy and heavy
healthy breathing in vivo predictions occurring at the 10th location (closest to the model inlet) and
2nd location (furthest from the inlet), respectively. It is seen that the heavy normal breathing
models maximum velocity is 116% larger than the normal healthy magnitudes for both locations.
This is due to 116% difference between the in vivo model expansions (16% for normal healthy
and 60% for heavy healthy breathing), during the same time period.

A

B
Figure 6.32 – 10th location for the (A) normal healthy human model (Re = 0.009) and the (B) heavy
healthy model (Re = 0.035).

Because the heavy healthy model has an in vivo percent expansion of 60%, a total of 0.8 mm3 is
inhaled each breath as compared to 0.2 mm3 for the normal healthy breathing condition (percent
expansion of 16%). This suggests that particles travel deeper into the heavy healthy breathing
model by convection alone for a single breath. Because each model has the same initial in vivo
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volume and breathing period, diffusion would also dominate in the heavy healthy model because
the deeper particles would have less of a distance to travel to deposit on the alveolar walls.
Similar to the normal healthy versus the normal emphysema case, residence time is irrelevant in
this situation because the in vivo breathing frequencies are identical.

A

B

Figure 6.33 - 2nd location for the (A) normal healthy human model (Re = 0.009) and the (B) heavy healthy
model (Re = 0.035).

6.5.5 – Heavy Healthy Breathing vs. Normal Emphysemic Breathing
Although the breathing conditions for a healthy heavy breather are very different from an
emphysematic breathing normally (shown in Table 6.6), the breathing conditions result in similar
Re (Re = 0.035). Even though the calculated in vivo Re are equal for heavy healthy and normal
emphysemic breathing, the time averaged in vivo flow rates at the model inlets for the normal
emphysemic breathing condition is 2x larger than the in vivo heavy healthy breathing (1.03E-3
mL/sec for normal emphy and 4.91E-4 mL/sec for heavy healthy). This is, again, due to the
larger initial volume of the emphysemic model (11x larger than the healthy model), and the
substantially larger percent expansion of the heavy healthy model (5.5x larger than the
emphysemic expansion). The difference between the two flow rates is found by the ratio of the
volume differences to the expansion differences (11x larger emphysemic volume / 5.5x larger
healthy expansion). Similarly, the in vivo velocity at the model inlet for the heavy healthy case,
however, is 2x larger than the normal emphysemic condition (3.7 mm/sec for heavy healthy and
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1.6 mm/sec for normal emphysema). These differences stem from the differences between the in
vivo duct diameters (emphysemic in vivo diameter is 2x the healthy).

The differences that exist between the in vivo flow fields were analyzed to compare the effects of
the healthy and emphysemic geometries for similar non-dimensional flow fields (Re = 0.035).
For example, Figure 6.34 represents the predicted in vivo flow fields that exist closest to the
model inlet for both the heavy healthy (10th location) and normal emphysemic (8th location)
models for an in vivo Re of 0.035 (refer to Figure 6.1 and Figure 6.20 for the laser plane
locations for the healthy and emphysemic models, respectively). The maximum in vivo heavy
healthy breathing velocity magnitude is 8.86E-4 m/s, occurring near the inlet of the model, while
the maximum normal emphysemic breathing in vivo magnitude is 2.69E-4 m/s; more than 3x less
than the maximum heavy healthy magnitude with a difference of 107%.

A

B
Figure 6.34 - (A) 10th location in the healthy heavy human model and the (B) 8th location of the normal
emphysemic model (in vivo Re = 0.035).

For further comparison, the 2nd locations were compared to illustrate the differences existing at
the furthest distances from the inlet of the model, again for an in vivo Re of 0.035 (Figure 6.35).
The maximum velocity occurring at this location in the normal breathing emphysemic model is
8.57E-5 m/s, representing a 63% difference from the heavy healthy model (1.64E-4 m/s).
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A

B
Figure 6.35 – 2nd location in the (A) heavy healthy human model and the (B) normal emphysemic model
(in vivo Re = 0.035).

Based on the in vivo breathing conditions and initial model volumes, the normal breathing
emphysemic model inhales two times as much fluid as the heavy breathing healthy model (1.6
mm3 versus 0.8 mm3, respectively). Similar to the conclusions made in section 6.5.3, the
difference in volume change indicates that particles would travel deeper into the emphysemic
model by means of convection. The larger volume change of the heavy breathing healthy model
(as compared to the normal breathing healthy), however, indicates that particles would travel
deeper into the heavy healthy breathing as compared to the normal breathing healthy. Therefore,
the travel distance required for deposition in the heavy healthy model is significantly less than
previously seen in the normal healthy model. This suggests that particles in the heavy healthy
model would diffuse at a much faster rate than in the emphysemic model even if the emphysemic
volume is 11x larger than the healthy model. Residence time continues to have little effect in
this case because the in vivo breathing frequencies are similar.
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Chapter 7: Conclusions and Discussion
7.1 – Remarks
The present research was successful in the execution of its predefined goals (Chapter 1):
1.

Create compliant hollow models
Two experimental model prototypes were created from in vivo healthy and
emphysemic human lung geometries. The healthy model was 19.4x in vivo size,
while the emphysemic model represented 8.9x in vivo dimensions. Compliant
models were then obtained for both experimental geometries using the dipping
techniques developed in our lab.

2.

Develop PIV setup capable of 3D flow field analysis
Stereoscopic particle image velocimetry (stereoPIV) techniques were successfully
employed to visualize the 3D fluid flows occurring in each of the experimental
models. An experimental setup was developed to accommodate the necessary
components in the system while a LabVIEW program was created to expand and
contract the compliant models based on the desired input parameters. A fluid
scaling analysis was performed to ensure that the in vivo flow fields were well
represented experimentally. Finally, the stereoPIV setup was validated by
comparing the results of a full experimental analysis of simple 3D bulb geometry
to the results of a CFD analysis.

3.

Complete stereoPIV analysis on healthy and emphysematous models
Using the validated setup, healthy and emphysemic models were analyzed and
compared. Specifically, the differences in model geometries were compared
along with the variations that occur in each of the flow fields (i.e. velocity
magnitudes and velocity distributions across a given plane). Finally, the
characteristics that affect particle transport were discussed and compared between
the healthy and emphysemic models.
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7.2 – Healthy versus Emphysemic Models
It was shown that major geometric differences exist between the healthy and emphysemic
geometries. The major difference separating the two models is the presence of potential
recirculation regions in the healthy model. These locations were determined based on defined
bulb structures that yield small ratios of alveolar depth to mouth diameter. The emphysemic
model, however, contained no such geometry. In fact, the overall appearance of the emphysemic
model appeared to contain two distinct sections merged into a single large alveolus. The
predicted in vivo flow fields yield reversible flow occurring everywhere in each model.
Therefore, the geometric differences had no impact on the presence of reversible or recirculating
flow.

The velocities occurring closest to the model inlet in the typical emphysemic breathing model
were larger than those found in the typical healthy breathing flow fields. Therefore, more
ventilation occurred in the typical breathing emphysemic model (as compared to the typical
breathing healthy model) because of the higher average flow rates at the model inlet. The
healthy model exhibited a very uniform flow field distribution with the magnitudes decreasing
from the center of the model out towards the wall. The emphysemic model, however, illustrated
a non-uniform spread. It was concluded that particles are more likely to deposit in the normal
healthy breathing model rather than in the normal breathing emphysemic model because of the
ratio of percent expansion to initial model volume. Even though particles would potentially
travel deeper into the emphysemic model, the distance required to deposit would be less for the
healthy normal breathing condition. These results agree with the previous studies of Oakes
(2010; 2008) and Sturm and Hofmann (2004) who studied the differences occurring between
normal healthy breathing and normal emphysemic breathing.

Because of the larger model percent expansion, the velocities occurring throughout the heavy
breathing healthy model were significantly larger than those seen in the normal breathing healthy
case (for all locations analyzed). In addition, because particles travel further into the heavy
breathing model, they have a higher tendency to deposit on the alveolar walls.
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The same flow field distributions occurred between the heavy breathing healthy and normal
breathing emphysemic comparison as was shown between the normal breathing healthy and
normal emphysemic breathing case. Because of the larger inlet flow rates, however, more
ventilation was seen in the normal breathing emphysemic case. Finally, it was concluded that
particles would be more likely to deposit in the heavy breathing healthy model as opposed to the
normal emphysemic model because of the larger percent expansion, and, therefore, expected
deeper penetration of the healthy breathing heavy model.

7.2.1 – Discussion of In Vivo Predictions
As shown in Chapter 2, the size and location of the inlet ducts for each model were arbitrarily
chosen to fit with the contours of the model. The below discussion aims to address how the
dimensions and locations of the inlet ducts and the final chosen models affects the in vivo
predictions as defined in section 6.5.

7.2.1.1 – Residence Time
Residence time is defined as the amount of time a particle has to deposit in the lung during a
single breath. It is determined based on in vivo conditions from literature; specifically breathing
frequency. The predicted residence times in this work are relevant to in vivo conditions because
the in vivo flow parameters were matched between the in vivo and experimental models;
assuming that the breathing frequency used for the entire lung is the same that occurs in
individual alveoli. Because residence time is related to the breathing frequency, the sizes of the
final model section and the duct diameter have no effect on particle residence time. The
residence time for emphysemic conditions is slightly lower than those seen in typical healthy
humans because the in vivo breathing period is smaller (3.7 seconds for typical emphysemic
conditions and 3.8 seconds for typical healthy conditions). Therefore, particles will have a
longer time to deposit in the healthy model as opposed to the emphysemic model. In this work,
the difference between typical healthy breathing and heavy healthy breathing is percent
expansion. Therefore, the residence times in these models are equal.
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7.2.1.2 – Particle Penetration Depth
Penetration depth is the distance a particle (either air or aerosol) is expected to travel into the
lung for a given breathing period, as measured by the distance from the position at the start of
inhalation. In our model, we predicted measurements from the duct entrance, which would
represent a particle that was already in the lung at the alveoli at the start of inhalation.
Penetration depth cannot be determined directly from the presented results since threedimensional pathlines are required. However, the 3D flow fields can be used in the future to
derive this information. For this work, we estimated relative penetration depth to inhalation
volume. The functional residual capacity (FRC) and tidal volume (inhaled volume) were taken
from literature and the expansion was calculated by the tidal volume / FRC. It should be noted
that penetration depth must be related to the location of the final position of a particle relative to
the model wall, since the wall is where gas exchange and particle deposition occurs. If we
assume that the lung expands uniformly in every lobe and alveoli, the percent expansion of the
model is directly related to in vivo expansions. Although absolute volume inhaled is directly
related to the size of the initial model selected, the desired percent expansion is not affected by
model or duct size. Therefore, relative penetration depth is not affected by the size of the model
or the duct diameter; it is related to the applied model expansion. In this work, we made
observations about the penetration depth relative to the inhaled volume (the percent of inhaled
volume relative to the total volume of the model). This comparison was completed for each of
the three cases (typical healthy versus typical emphysemic breathing, typical healthy versus
heavy healthy breathing, and heavy healthy versus typical emphysemic breathing) and is
presented in the above section (section 7.2). In conclusion, even though the penetration depth is
higher in the emphysemic model as compared to the typical healthy model, the relative
penetration depth is smaller because the volume required to penetrate is much larger in the
emphysemic as compared to the healthy model; for the models chosen in this work.

If a different model were created with a larger duct diameter, for example, the model volume
would be less due to a smaller required scaling factor to obtain in vivo dimensions. If the same
input parameters were applied to this new model, specifically percent expansion, the relative
penetration depths would be identical. Therefore, the penetration depth predictions presented
above are very relevant to in vivo.
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7.2.1.3 – Particle Deposition
Deposition by diffusion and sedimentation depends on both penetration depth and residence
time. Penetration depth defines how far a particle is carried in from the convective motion of the
wall expansion and how much distance is remaining to get to the wall after inhalation.
Residence time is how long particles are in the lung or the time allowed for particles to deposit.
Because the breathing periods are similar for healthy and emphysemic conditions, the residence
times are analogous. As described above, the penetration depths in typical emphysemic models
are larger than those seen in typical healthy models because of the model percent expansion.
The volume to penetrate in the typical emphysemic model, however, is much larger than the
typical healthy model, which yields lower deposition by diffusion in the typical emphysemic
model as compared to the typical healthy model. Because the heavy healthy model has a larger
percent expansion, however, deposition is even more prevalent in the heavy healthy model as
compared to the typical emphysemic model. Similarly, deposition is greater in the heavy healthy
model as compared to the typical healthy model because of the large difference in percent
expansion. Note that we are assuming a lumped capacitance approach to these predictions. This
assumes that diffusion from the streamline occurs only after a particle is completely inhaled. In
reality, however, drifting from the streamline occurs during inhalation.

7.2.1.4 – Flow Rate
The input flow rates applied to each model were determined based on the initial model volume,
breathing period, and desired percent expansion. If different model dimensions were used,
however, the flow rates would be affected by the initial model volume of the model. From
Chapter 2, the model size is determined based on the scaling factor applied in order to achieve
the appropriate duct diameter. Therefore, if the duct diameter’s arbitrary dimension were
increased, for example, the scaling factor would be decreased, therefore decreasing the initial
volume of the model (assuming the same model location was selected from the original cast).
Assuming the same input breathing period and percent expansion, a lower input flow rate would
result in a model with a larger in vivo duct diameter as opposed to the models used in this work.
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7.2.1.5 – Velocity Fields
The experimental velocity fields determined from stereoPIV were scaled back to represent in
vivo flow fields using in vivo flow conditions (see Chapter 3). These in vivo fields allowed us to
demonstrate the importance of diffusive relative to convective motion, which is needed to model
air and particle flow. Similar to the flow rates, the velocity field magnitudes would change if
different models were created other than the ones used in this work. Again, for example, if a
larger arbitrary duct diameter was chosen, the resulting model volume would be smaller than that
seen in this work. This would yield smaller experimental velocity magnitudes. The resulting in
vivo flow fields would also have smaller magnitudes because the ratio of the experimental
diameter to the in vivo diameter would be less than that used in this work.

7.3 – Limitations of Work
One limitation in the current research is the settings of the cameras used to acquire raw PIV
images. The most accurate setting would be 90° between the cameras, but because of restricted
optical access, smaller angles were required, reducing the accuracy of the results, particularly in
the z-direction as shown in the bulb model. Therefore, to optimize the vector field results,
Scheimpflug mounts are traditionally used. In this work, however, Scheimpflug mounts were
not used. If future work is performed, the use of these mounts is highly recommended to
optimize the accuracy of the experiments (especially the z-component of velocity).

Another limitation of the experimental setup involved the location of the syringe pump used to
expand and contract the experimental models. Because the pump was located to one side of the
model, the rig had a tendency to non-uniformly expand the compliant models during
experimentation, and was illustrated in the boiling flask validation. This non-uniform expansion
resulted in the velocities on the left side of the model being less than the predicted values with
the right side velocities being higher than the predictions.

A final limitation existing in the experimental setup dealt with the tracer particles. Over long
periods of time, the particles had a tendency to disperse unevenly throughout the model.
Unfortunately, the only way to re-mix the particles required the entire model to be removed from
the setup. Because of this movement in particles, experiments for a given model needed to be
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completed in a single setting as to not detect the rising of the particles. This limitation, however,
had no affect on the results of this study.

7.4 – Future Work
The conclusions generated from the in vivo predictions related to particle transport occurring in
healthy and emphysemic geometries. Quantitative results for particle penetration depths were
unable to be calculated in this work because it was unclear how potential particles would travel
in a non-symmetric model. Pathlines were also unable to be calculated because time elapsed
sequences were not analyzed. It is suggested for future work, however, to extract 3D pathlines to
determine the penetration depths and general paths of particles throughout healthy and
emphysematous models. 3D pathlines would also allow for more accurate predictions of
convective transport.

As stated above, the accuracy of the experimental results was reduced because the Scheimpflug
mounts were not used in the experimental setup. If future stereoPIV work is completed, the use
of these mounts is highly recommended to maximize the accuracy of the desired outputs. These
mounts would also increase the quality of the raw images because the entire field of view would
be in focus; optimizing the correlation peaks in the image processing.

It was demonstrated that a measured conversion factor is desired to compare to the factor
calculated by Insight. Although this was done for the boiling flask model, it was not completed
for the emphysemic or healthy models. Therefore, the results of the healthy and emphysemic
models contain a small amount of error from the pixel to length conversions (as calculated in
Insight 3G). It is suggested to measure the conversion factors for the laser plane locations used
in the reported results and scale the experimental and predicted in vivo velocity fields by the ratio
of the measured to the calculated conversion factors. Finally, compare the differences between
the results from the two geometries when using the calculated factor versus the measured factor.
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